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 1 
Summary 
 
The Drosophila Pax2 (D-Pax2) gene encodes a paired-domain containing transcription 
factor, most closely related to the vertebrate Pax2/5/8 subfamily.  Like its mammalian 
counterpart, D-Pax2 plays an important role in the development of several sensory organs.  
During eye development, it is required for the proper specification and differentiation of cone 
and primary pigment cells.  The spa enhancer regulating D-Pax2 transcription in the 
developing eyes has been mapped previously to the 4th intron.  The D-Pax2 protein also plays 
a vital role in the developing peripheral nervous system (PNS), where it regulates the proper 
specification and differentiation of shaft and sheath cells of mechanosensory bristles.  The sv 
enhancer, regulating D-Pax2 transcription in the PNS, is located upstream of the D-Pax2 
transcription initiation site.  In my thesis, I have addressed two important aspects of the 
transcriptional regulation of D-Pax2 as well as its function in the developing central nervous 
system (CNS). 
 
An intriguing property of enhancers is that they specifically target and activate transcription 
from their cognate promoter.  The regulatory mechanisms responsible for enhancer-promoter 
specificity are not well understood.  Using the complex D-Pax2 locus, which includes several 
tissue-specific enhancers and two different promoters, I was able to investigate this question 
within a single gene since the enhancers act only through one of the two promoters.  The sv 
enhancer and the spa enhancer specifically activate transcription from the PNS promoter, 
whereas the CNS enhancer specifically activates transcription from the CNS promoter.  The 
specificity between these enhancers and their cognate promoters is achieved by promoter-
enhancer compatibility (or incompatibility) rather than promoter-competition or an insulator 
element.  It is further shown that promoters rather than enhancers are controlling this 
enhancer-promoter compatibility, since the sv and CNS enhancers, which specifically 
activate their cognate promoters, can also activate the P-element promoter. 
 
Initially, enhancers were thought to activate transcription only in cis.  However, the discovery 
and genetic studies of a phenomenon called transvection illustrated that enhancers can also 
activate transcription in trans from the promoter located on the homologous chromosome.  I 
report here on the phenomenon of transvection at the D-Pax2 locus.  By genetic tests I could 
demonstrate that the spa enhancer exhibits transvection by activating the PNS promoter on 
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the other D-Pax2 allele.  However a second enhancer of this locus, the sv enhancer, activating 
the same promoter in cis does not display transvection.  Thus, two enhancers of a single gene 
locus, activating a single cognate promoter, differ in exhibiting transvection.  These results 
demonstrated for the first time that not all enhancers have the ability to activate in trans and 
that the property of an enhancer to activate in trans depends on the enhancer rather than the 
promoter. 
 
Like its vertebrate homolog, D-Pax2 is also expressed in the developing CNS.  Large D-Pax2 
deletion alleles were generated that, lacking both promoters, are complete null alleles for all 
known D-Pax2 functions.  Analysis of these alleles showed that D-Pax2 plays an important 
role in CNS development.  Loss of D-Pax2 function in the CNS is lethal during the second 
larval instar.  A crucial cis-regulatory region responsible for D-Pax2 expression in the CNS 
was mapped to the highly conserved 6th intron.  D-Pax2 transcription under control of this 
intron rescues many but not all CNS null animals to adulthood.  This suggests that additional 
CNS enhancer elements are required for complete rescue. 
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Zusammenfassung 
 
Das Drosophila Pax2 Gen (D-Pax2) kodiert für einen Paired-Domänen Transkriptionsfaktor, 
welcher der Pax2/5/8 Unterfamilie bei Wirbeltieren sehr ähnlich ist.  Wie sein Pendant in 
Säugetieren spielt D-Pax2 eine wichtige Rolle bei der Entwicklung mehrerer Sinnesorgane.  
Während der Augenentwicklung ist es für die korrekte Spezifikation und Differenzierung der 
Kegel- und primären Pigmentzellen erforderlich.  Schon früher wurde der spa-Enhancer, der 
die D-Pax2 Expression in den sich entwickelnden Augen reguliert, im vierten Intron kartiert.  
Das D-Pax2 Protein spielt auch eine entscheidende Rolle in der Entwicklung des peripheren 
Nervensystems (PNS), wo es die richtige Spezifikation und Differenzierung der Schaft- und 
Mantelzellen der mechanosensorischen Tastborsten steuert.  Der sv-Enhancer, der die D-
Pax2 Transkription im PNS steuert, befindet sich oberhalb des D-Pax2 Transkriptionstarts.  
In meiner Dissertation habe ich zwei wichtige Aspekte der Transkriptionsregulation von D-
Pax2 und die Funktion von D-Pax2 in der Entwicklung des zentralen Nervensystems (ZNS) 
untersucht. 
 
Eine interessante Eigenschaft von Enhancern ist, dass sie gezielt ausschliesslich ihren 
eigenen Promotor aktivieren.  Die für diese Enhancer-Promotor Spezifität verantwortlichen 
Mechanismen sind nicht gut verstanden.  Mit dem komplexen D-Pax2 Lokus, der mehrere 
gewebespezifische Enhancer und zwei verschiedene Promotoren hat, konnte ich diese Frage 
mit einem einzelnen Gen untersuchen, da die Enhancer jeweils nur auf einen der Promotoren 
wirken.  Der sv-Enhancer und der spa-Enhancer aktivieren spezifisch die Transkription des 
PNS-Promotors, hingegen der ZNS-Enhancer die Transkription des ZNS-Promotors.  Die 
Spezifität zwischen diesen Enhancern und ihren eigenen Promotoren wird durch Promotor-
Enhancer-Kompatibilität (oder Inkompatibilität) zwischen diesen Enhancern und 
Promotoren, nicht jedoch durch Promotor-Kompetition oder ein Insulator DNA-Element 
gesteuert.  Es wurde ferner gezeigt, dass die Promotoren und nicht die Enhancer entscheidend 
sind für die Kontrolle dieser Enhancer-Promotor-Kompatibilität, da sowohl der sv- als auch 
der ZNS-Enhancer, die ihren eigenen Promotor spezifisch aktivieren, auch den P-Element-
Promotor aktivieren können. 
 
Früher wurde angenommen, dass Enhancer die Transkription nur in cis aktivieren können.  
Aber die Entdeckung und Untersuchungen des “Transvektion” Phänomens haben gezeigt, 
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dass Enhancer auch die Transkription in trans vom Promotor, der sich auf dem homologen 
Chromosom befindet, aktivieren können.  Ich konnte zeigen, dass Transvection auch beim D-
Pax2 Lokus vorkommt.  Mit genetischen Tests fand ich heraus, dass der spa-Enhacer zu 
Transvektion fähig ist, da er die Transkription des PNS-Promotors auf dem anderen D-Pax2 
Allel aktivieren kann. Allerdings zeigt ein zweiter Enhancer dieses Lokus, der sv-Enhancer, 
der denselben Promotor in cis aktivieren kann, keine Transvection.  So können sich zwei 
Enhancer eines Gens, die den gleichen Promotor aktivieren, in ihrer Fahigkeit zur 
Transvektion unterscheiden.  Insgesamt konnte zum ersten Mal gezeigt werden, dass nicht 
alle Enhancer eines Gens in der Lage sind, in trans zu aktivieren und dass die Eigenschaft 
eines Enhancers in trans zu aktivieren vom Enhancer und nicht vom Promotor abhängt. 
 
Wie sein homologes Gen in Wirbeltieren wird D-Pax2 auch während der Entwicklung des 
ZNS exprimiert. Allele mit grossen D-Pax2 Deletionen wurden isoliert, die, da beide 
Promotoren entfernt wurden, Null-Allele für alle bekannten D-Pax2 Funktionen sind.  Die 
Analyse dieser Allele hat gezeigt, dass D-Pax2 eine wichtige Rolle bei der Entwicklung des 
ZNS spielt.  Der Verlust der D-Pax2 Funktion im ZNS ist im zweiten Larvenstadium letal.  
Eine für die D-Pax2 Expression im ZNS verantwortliche cis-regulatorische Region konnte 
dem hoch konservierten sechsten Intron zugeordnet werden.  D-Pax2 Transkription unter der 
Kontrolle dieses Introns rettet viele, aber nicht alle ZNS-Null Tiere bis zum Erwachsenen-
alter.  Dies legt den Schluss nahe, dass für eine vollständige Rettung zusätzliche ZNS 
Enhancer-Elemente erforderlich sind. 
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Chapter 1 
 
General Introduction 
 
Pax genes, originally discovered in Noll’s lab on the basis of the gene network concept 
(Frigerio et al., 1986; Bopp et al., 1986; Noll, 1993), encode a family of transcription factors 
comprising a highly conserved DNA binding paired domain.  These genes play a significant 
role in various developmental processes of vertebrates and invertebrates (Frigerio et al., 1986; 
Bopp et al., 1986; Noll, 1993).  D-Pax2, also known as shaven (sv) or sparkling (spa), is the 
Drosophila homolog of the vertebrate Pax-2/5/8 gene subfamily (Fu and Noll, 1997; Fu et al., 
1998).  Like its mammalian counterpart, it plays an important role in the development of 
several sensory organs (Fu and Noll, 1997; Fu et al., 1998; Kavaler et al., 1999; Shi, 2001).  
D-Pax2 is expressed in the developing peripheral and central nervous system (PNS and CNS) 
and in developing eyes (Fu and Noll, 1997; Fu et al., 1998; Kavaler et al., 1999; Shi, 2001).  
For some time, the sv and spa mutant alleles were thought to represent two neighboring genes, 
but it was later shown by our lab that these are mutations in two different tissue-specific 
enhancers of D-Pax2, the sv or PNS enhancer and the spa or eye enhancer (Fu et al., 1998). 
 
Role of D-Pax2 in the Drosophila PNS development 
The mechanosensory bristle is an external sensory organ of the adult Drosophila and 
comprised of four cell types, a tormogen (socket cell), trichogen (shaft cell), thecogen (sheath 
cell), and neuron.  These arise from a single sensory organ precursor cell (SOP) through a 
stereotypical series of asymmetric divisions (Fig. 1) (for review, see Posakony, 1994).  SOPs 
are selected from a small group of cells, the proneural cluster, endowed with SOP fate 
potential by the expression of the proneural genes of the achaete-scute complex which encode 
bHLH transcription factors.  After specification of the SOP, all other cells of the proneural 
cluster are inhibited from becoming SOPs through a process called lateral inhibition (Ghysen 
et al., 1993).  The primary SOP cell, PI, divides asymmetrically to produce two sibling cells, 
PIIa and PIIb (Fig. 1B).  The PIIa cell divides to produce the shaft and socket cell, while the 
PIIb cell divides to give rise to a PIIIb and a glial cell.  The PIIIb cell again divides 
asymmetrically to generate a neuron and a sheath cell (Fig. 1B) (Gho et al., 1999; Reddy and 
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Rodrigues, 1999).  Recently, it has been shown that the glial cell generated in this lineage 
undergoes apoptosis (Fichelson and Gho, 2003). 
 
 
Fig. 1.  Structure and lineage of adult mechanosensory bristle. 
(A) Structure of adult mechanosensory bristles (adapted from Fabre et al., 2008).  The mature 
sensory organ comprises four cells, a shaft cell (brown), socket cell (yellow), a 
monodendritic sensory neuron (green) and a sheath cell (red).  (B) Cell lineage of 
mechanosensory bristle, with terminally differentiated socket (So), shaft (Sf), glial (G), 
sheath (Sh) cell, and neuron (N). 
 
 
D-Pax2 plays a vital role in the developing larval PNS and adult mechanosensory bristles.  In 
the latter it is required for the proper specification and differentiation of shaft and sheath cells 
(Fu et al., 1998; Kavaler et al., 1999).  It is expressed in SOPs and all cells of this lineage (Fu 
et al., 1998; Kavaler et al., 1999).  By mid-pupal stages, it is no longer expressed in the socket 
and neuron, but continues to be expressed at high levels in sheath and shaft cells (Kavaler et 
al., 1999).  The hypomorphic sv alleles, svn and svde, exhibit reduced or loss of shaft structures 
of all bristles, the so-called shaven phenotype (Fu et al., 1998).  However, svΔ122 mutants (Fig. 
1 of Chapter 2) that fail to express D-Pax2 in the PNS and eye die as first instar larvae 
(Michael Daube and Erich Frei, unpublished), which suggests that D-Pax2 function in the 
PNS is vital.  The sv enhancer responsible for the D-Pax2 expression in the PNS has been 
mapped to a region upstream of the PNS promoter (Fu et al., 1998; Kavaler et al., 1999).  
Further characterization of a minimal sv enhancer delimited it to a 760 bp fragment, 1.6 kb 
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upstream of the initiation site of the PNS promoter (Shi, 2001).  Since one copy of a rescue 
transgene under the control of this region in a null mutant leads to bristles that are still 
abnormal, some enhancer elements must be located outside this region.  The 760 bp minimal 
sv enhancer was further divided into two parts, an early and a late element, which support 
transcription during the early and late phases of development of both the larval and the adult 
mechanosensory organs.  In addition, the early element is crucial for rescuing the lethality of 
svΔ122 mutants, whereas both the early and late elements are required for the bristle 
development (Shi, 2001). 
 
Role of D-Pax2 in eye development 
Each Drosophila compound eye consists of about 800 unit structures, called ommatidia, that 
are arranged in a regular symmetrical fashion.  Each ommatidium consists of eight 
photoreceptor (R) cells, R1-R8, four lens-secreting cone cells, and two primary pigment cells, 
and shares six secondary and three tertiary pigment cells as well as three mechanosensory 
bristles with neighboring ommatidia (Wolff and Ready, 1993).  The compound eye develops 
from a monolayer of undifferentiated epithelial cells, the eye imaginal disc.  During the third 
larval instar, pattern formation begins as a wave of morphogenesis moving from posterior to 
anterior across the disc.  This wave is marked by a depression in the surface of the disc, the 
morphogenetic furrow, behind which small and precisely distributed cell clusters differentiate 
into photoreceptor neurons (Greenwald and Rubin, 1992; Wolff and Ready, 1993).  Initially, 
R8 is singled out from each proneural cluster.  Next, the paired photoreceptors R2/R5 are 
recruited by R8, followed by the recruitment of the R3/R4 pair and the R1/R6 pair.  R7 is the 
last photoreceptor that is recruited into each developing ommatidium.  After the recruitment 
of R cells, four cone cells are added to each ommatidium, and finally pigment cells are 
recruited (Wolff and Ready, 1993).  D-Pax2 plays an important role in the development of 
cone and primary pigment cells.  In the D-Pax2 mutant spapol, in which the eye-specific spa 
enhancer is deleted, development of cone and primary pigment cells is disturbed and produces 
a strong rough eye phenotype, the sparkling phenotype (Fu and Noll, 1997).  The cone cell-
specific transcription of D-Pax2 is regulated by the combinatorial action of the transcription 
factor Lozenge and the nuclear effectors of the EGFR and Notch signaling pathways (Flores et 
al., 2000).  D-Pax2 and tramtrack control proper cone cell differentiation (Shi, 2001). 
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Transcriptional regulation and enhancer-promoter specificity 
Development of a multi-cellular organism depends on the precise and coordinated expression 
of several hundreds and thousands of genes in a spatially and temporally controlled manner.  
This is largely regulated at the transcription level.  Transcriptional activation is an intriguing 
and complicated process that depends on a number of cis-regulatory elements, which include 
enhancers, promoters, insulators, polycomb response elements (PREs), and trithorax response 
elements (TREs) (reviewed by Dorsett, 1999; Arnosti, 2003; Bondarenko et al., 2003; 
Schwartz and Pirrotta, 2007; Schuettengruber et al., 2007).  A promoter is the minimal stretch 
of contiguous DNA sequence that is sufficient to direct accurate initiation of transcription by 
the RNA polymerase II machinery in the presence of an enhancer.  Typically, a promoter 
comprises a transcription initiation site and extends tens or hundreds of nucleotides upstream 
or downstream of the initiation site.  There are several sequence motifs commonly found in 
promoters, which include the TATA box, initiator (Inr), downstream core promoter element 
(DPE) and TFIIB recognition element (BRE) (Juven-Gershon et al., 2008).  These promoter 
elements are found in many but not all promoters, which suggests that other promoter 
elements might exist mediating transcription initiation.  Apart from controlling transcription 
initiation, promoters can mediate the enhancer-specificity (Butler and Kadonaga, 2001). 
 
Transcriptional enhancers are cis-regulatory elements responsible for gene activation specific 
in space and time.  Often enhancers are found either upstream or downstream of promoters 
and are able to work in both orientations over long distances (reviewed by Serfling et al., 
1985; Blackwood and Kadonaga, 1998; Dillon and Sabbattini, 2000).  These elements 
contain binding sites for different transcriptional activators that, upon binding to these 
sequences, specifically activate transcription from the linked cognate promoter.  In general, 
transcriptional activators contain a DNA binding domain that enable it to bind to a specific 
enhancer sequence and an activation domain that permits activation of transcription at the 
promoter.  Activation domains can turn on transcription by either recruiting the polymerase II 
machinery (Ptashne and Gann, 1997) or by recruiting chromatin modifying factors that lead 
to an increased accessibility of the transcription initiation site to the transcription machinery 
(reviewed by Workman and Kingston, 1998). 
 
An important question concerning the transcriptional regulation of a gene is how its 
enhancers find and specifically activate their cognate promoters rather than other non-cognate 
promoters (Li and Noll, 1994).  Previous studies mainly suggested three models of how this 
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is achieved: (i) the enhancer-promoter compatibility model, (ii) the promoter competition 
model, and (iii) the insulator model (Fig. 2).  In the first model, transcriptional activators 
binding to an enhancer can only interact with proteins bound to their cognate promoter but 
not those bound to other neighboring promoters (Fig. 2A; Li and Noll, 1994; Merli et al., 
1996).  In the second model, an enhancer that is capable of activating several promoters 
preferentially activates the strongest promoter (Fig. 2B; Calhoun et al., 2002; Calhoun and 
Levine, 2003; Akbari et al., 2008).  The strength of a promoter depends on the specific 
promoter elements, like TATA box and initiator element, or on promoter-tethering elements 
that provide assistance in the interaction of the promoter with the enhancer.  In contrast to the 
first model, here mutations affecting the strong promoter can lead to the activation of (the) 
other promoter(s).  In the third model, insulator DNA elements, located between an enhancer 
and promoters, prevent the activation of the promoters by the enhancer (Fig. 2C; reviewed by 
Geyer, 1997; West et al., 2002; Gaszner and Felsenfeld, 2006).  Accordingly, insulators are 
frequently found between adjacent genes. 
 
Transvection 
Pairing of homologous chromosomes or chromosomal regions exert profound effects on gene 
activation or repression, collectively termed trans-sensing effects (Tartof and Henikoff, 1991; 
Henikoff and Comai, 1998).  In Drosophila, like other Diptera, homologous chromosomes 
are always paired in somatic cells (Stevens, 1908; Metz, 1916).  Gene activation in trans is 
generally called transvection (reviewed by Pirrotta, 1999; Wu and Morris, 1999; Duncan, 
2002; Kennison and Southworth, 2002; Sipos and Gyurkovics, 2005).  In 1954, Lewis first 
coined the term transvection for the phenomenon of pairing-dependent inter-allelic 
complementation observed at the Ultrabithorax (Ubx) locus of Drosophila (Lewis, 1954).  
Since then, this phenomenon has been reported for several other genes in Drosophila, which 
include Abdominal-B (Abd-B), apterous (ap), decapentaplegic (dpp), eyes absent (eya), Sex 
combs reduced (Scr), vestigial (vg), yellow (y), whitespeckled (wsp), and wings-up A (wup A) 
(Korge, 1981; Gelbart, 1982; Davison et al., 1985; Geyer, 1990; Martinez-Laborda et al., 
1992; Leiserson et al., 1994; Sipos et al., 1998; Morris et al., 1999; Southworth and 
Kennison, 2002; Coulthard et al., 2005; Gohl et al., 2008).  Apart from Drosophila, 
transvection or transvection-like effects have been reported in fungi, plants and mammals, 
where there is no extensive homologous chromosome pairing (reviewed by Pirrotta, 1999; 
Wu and Morris, 1999; Duncan, 2002; Kennison and Southworth, 2002; Sipos  
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Fig. 2.  Regulation of enhancer-promoter specificity. 
Three models illustrate how the enhancer E of gene A can specifically target its cognate 
promoter A.  (A) Specificity is achieved by the enhancer-promoter compatibility, where 
factors binding to the enhancer can only interact functionally with the factors binding to the 
cognate promoter, but not with those bound to the other promoter B.  (B) Specificity is 
provided by promoter competition, where a strong promoter A competes with the weak 
promoter B for activation by the enhancer.  (C) An insulator regulates the enhancer-promoter 
specificity.  The enhancer E activates promoter A but cannot activate the promoter B because 
an insulator is located between the enhancer and promoter B. 
 11 
and Gyurkovics, 2005).  Moreover, it has been demonstrated that the entire Drosophila 
genome is generally permissive for transvection (Chen et al., 2002). 
 
Generally, inter-allelic complementation is observed between two classes of alleles, (i) 
mutations of the enhancer, and (ii) mutations of the promoter or coding region (Fig. 3).  
Transvection studies of the y gene suggested two models for the mechanism of transvection 
(Morris et al., 1998; Morris et al., 1999).  The first and widely accepted model is based on the 
ability of the enhancer to activate transcription from the cognate promoter on the paired 
homologous chromosome (Fig. 3).  In the second model, an insulator inserted between the 
enhancer and promoter is bypassed through a change in gene structure that depends on allelic 
pairing (Morris et al., 1998; Morris et al., 1999). 
 
 
 
 
Fig. 3.  Model of transvection. 
The enhancer deletion allele, ΔE, of gene X is transcriptionally activated through its intact 
promoter by the enhancer of the paired promoter deletion allele, ΔP, of gene X.  Homozygous 
ΔE or ΔP mutants have no gene X function because they lack the enhancer or promoter.  
However, in the transheterozygous combination of ΔE/ΔP, a functional gene X product is 
produced.  This phenomenon of inter-allelic complementation, termed transvection, results 
from the ability of an enhancer to activate transcription from its cognate promoter located on 
the homologous chromosome in a pairing-dependent manner. 
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An important aspect of transvection is its dependence on chromosomal pairing.  Disruption of 
allelic pairing leads to the loss of transvection.  If one allele is displaced to a different 
chromosomal location by translocation, inter-allelic complementation is abrogated.  Hence, 
transvection depends on close apposition of the enhancer and promoter.  Apart from 
chromosomal pairing, most but not all the instances of transvection are dependent on the 
function of zeste (z) (Lewis, 1954; Gelbart and Wu, 1982; Geyer et al., 1990; Leiserson et al., 
1994; Hopmann et al., 1995; Duncan, 2002; Southworth and Kennison, 2002; Coulthard et 
al., 2005).  Zeste is a DNA binding protein that is capable of forming self-aggregates and 
believed to help bringing the homologous chromosomes into close proximity. 
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Chapter 2 
 
Enhancer-promoter compatibility regulates the transcriptional 
specificity of the D-Pax2 gene during Drosophila development 
 
Summary 
Enhancer-promoter specificity has been a fundamental problem in eukaryotic gene 
transcription.  How an enhancer specifically activates transcription from its cognate promoter 
is not well understood.  Here, we have investigated the basis of the specificity of enhancer-
promoter interactions at the D-Pax2 locus in its own chromatin environment.  The D-Pax2 
gene is transcribed from two different promoters, the PNS promoter and the CNS promoter, 
in a tissue-specific fashion.  Interestingly, the D-Pax2 enhancers show specificity for only 
one of the two promoters.  The shaven (sv) enhancer, a PNS-specific enhancer, and the 
sparkling (spa) enhancer, an eye-specific enhancer, specifically activate the PNS-promoter 
and do not activate the CNS-promoter.  The CNS enhancer is specific for the CNS promoter 
and does not activate the PNS promoter.  We have also shown that the compatibility between 
enhancer and promoter, rather than promoter competition or insulator DNA, mediates the 
enhancer-promoter specificity.  Finally, our results show that the promoters rather than the 
enhancers control the enhancer-promoter specificity. 
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Introduction 
Development of multicellular organisms requires precise and coordinated activation of 
thousands of genes in a spatially and temporally regulated manner.  This is controlled by a 
number of cis-regulatory elements, including enhancers, promoters, insulators, polycomb 
response elements (PREs), and trithorax response elements (TREs) (Reviewed by Dorsett, 
1999; Arnosti, 2003; Bondarenko et al., 2003; Schwartz and Pirrotta, 2007; Schuettengruber 
et al., 2007).  Transcriptional enhancers are cis-regulatory DNA elements responsible for the 
spatial and temporal specific activation of gene expression.  Enhancers are often found 
upstream or downstream of the transcription initiation site and able to work in both 
orientations at long-range (reviewed by Serfling et al., 1985; Ptashne, 1986; Blackwood and 
Kadonaga, 1998; Sipos and Gyurkovics, 2005; Dillon and Sabbattini, 2000).  Enhancers 
contain cluster of binding sites for specific transcription factors, which upon binding to these 
sequences recruit other activators or chromatin modifiers leading to the initiation of 
transcription by RNA polymerase II (RNAP II) from the linked core promoter.  A core 
promoter contains distinct core promoter sequence elements that mediate recruitment of the 
general transcription machinery and specify the accurate RNAP II transcription initiation 
(reviewed by Butler and Kadonaga, 2002).  Several core promoter elements have been 
discovered, which include the TATA box, the initiator element, and the downstream 
promoter element (DPE) (Kadonaga, 2002). 
 
One of the intriguing properties of enhancers is that they specifically activate their cognate 
promoter rather than other promoters, for example, that of a neighboring gene.  Studies on 
enhancer trap lines and position effects of transgenes suggest that several enhancers can also 
activate other heterologous promoters (Kania et al., 1995; Bier et al., 1989; Lee and Wu, 
2006).  DNA aberrations, like gene displacements or mutations in cis-regulatory elements, 
disturb the normal gene expression that may lead to a diseased state (reviewed by Kleinjan 
and van Heyningen, 2005).  Hence, studies elucidating the mechanism of transcriptional 
regulation are indispensable.  Despite considerable progress in understanding the 
transcriptional regulation of genes, the mechanism controlling enhancer-promoter specificity 
is not well understood. 
 
Previous work has proposed mainly three different models for the enhancer-promoter 
specificity: (i) the enhancer-promoter compatibility, (ii) promoter competition, and (iii) 
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insulator DNA elements.  In the first model, the individual properties of enhancers and 
promoters determine the transcriptional specificity (Li and Noll, 1994; Merli et al., 1996).  In 
other words, the proteins binding to the enhancer form a stable and functional interaction 
only with the proteins binding at the cognate promoter, but not with the proteins binding at 
other promoters.  In the second model, a shared enhancer capable of activating several 
promoters prefers to activate only one promoter, which is then called the strongest promoter 
(Calhoun et al., 2002; Calhoun and Levine, 2003).  Here the various promoters compete for 
interaction with the same enhancer and the strongest interaction wins.  If one removes the 
strongest promoter, one of the other promoters will be activated, whereas in the enhancer-
promoter compatibility model removal of the activated promoter does not result in the 
activation of one of the others.  Promoter proximal tethering elements have been discovered 
that regulate this type of promoter-preference (Calhoun et al., 2002; Lin et al., 2003; Akbari 
et al. 2008).  In the third model, insulator DNA elements block nonspecific enhancer-
promoter interactions.  Insulators are DNA elements, which block the activation of a gene by 
an enhancer when they are located between the enhancer and the promoter of the gene 
(reviewed by Geyer, 1997; West et al., 2002; Gaszner and Felsenfeld, 2006).  Generally, 
insulators are found between genes, such that enhancers of a particular gene are allowed to 
activate only their cognate promoter. 
 
In this study, we have analyzed the enhancer-promoter specificity at a single gene locus, that 
of the D-Pax2 gene.  Interestingly, two different tissue-specific enhancers of D-Pax2 activate 
only one of the two promoters of the gene.  We have found that the transcriptional specificity 
at this locus is established by the compatibility between the enhancers and promoters rather 
than by promoter competition or through an insulator DNA element.   Finally, we have 
shown that it is the promoters rather than the enhancers that regulate the enhancer-promoter 
specificity. 
 
 
Results 
 
The cis-regulatory elements of the D-Pax2 locus 
The D-Pax2 gene, also known as shaven (sv) or sparkling (spa), is the Drosophila homolog 
of the vertebrate Pax-2/5/8 subfamily.  Thus, it encodes a paired-domain containing 
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transcription factor (Fu and Noll, 1997; Fu et al., 1998; Kavaler et al., 1999).  Like its 
mammalian counterpart, D-Pax2 plays an important role in several developing sensory 
organs (Fu and Noll, 1997; Fu et al., 1998; Kavaler et al., 1999).  In Drosophila, D-Pax2 is 
expressed in the developing embryonic and larval peripheral nervous system (PNS) as well as 
in the corresponding larval and adult sensory organs.  In adult mechanosensory bristles, it 
regulates the proper specification and differentiation of the shaft and sheath cells (Fu et al., 
1998; Kavaler et al., 1999).  The sv enhancer regulating D-Pax2 expression in the PNS has 
been mapped upstream of the PNS promoter (Fig. 1; Kavaler et al., 1999; Shi, 2001).  The 
two hypomorphic sv alleles, shaven-naked (svn) and shaven-depilate (svde), which contain 
insertions of transposable elements in the sv enhancer, display the shaven phenotype, i.e., 
strong reduction and loss of bristles all over the body (Fu et al., 1998).  Apart from its role in 
the PNS, D-Pax2 also plays an important role in eye development, where its function is 
required for the proper specification and differentiation of the cone and primary pigment cells 
(Fu and Noll, 1997, Flores et al., 2000).  The eye-specific spa enhancer has been mapped to 
the 4th-intron (Fig. 1; Fu and Noll, 1997).  The spapol allele, which is a deletion uncovering 
the third and fourth exon and the spa enhancer (Fig. 1), displays a strong rough eye 
phenotype (Fu and Noll, 1997).  Previously the Drosophila sv and spa alleles were thought to 
represent two different genes, but our lab has shown that they are mutations in two different 
tissue-specific enhancers of the D-Pax2 gene (Fu et al., 1998).  In addition to its expression in 
the PNS and eye, D-Pax2 is expressed in the embryonic CNS (Fu and Noll, 1997). 
 
D-Pax2 is transcribed from two different promoters 
Previously it was thought that D-Pax2 is transcribed from a single promoter.  However, 
studies based on two D-Pax2 point mutant alleles, svE67 and svE69, and a promoter deletion 
allele, svΔ122, led to the discovery of another promoter of the D-Pax2 locus.  The svE67 allele 
contains a premature stop codon in the 4th exon, while the svE69 allele contains a stop codon in 
the 7th exon.  Homozygous svE69 embryos showed complete loss of D-Pax2 expression in 
PNS and CNS, whereas in svE67 embryos expression is abolished only in the PNS, but not in 
CNS.  This suggested that there is another promoter from which D-Pax2 is transcribed in the 
CNS (data not shown, E. Frei, M. Daube, and M. Noll, unpublished).  The svΔ122 allele was 
generated by E. Frei and M. Daube by imprecise excision of the P-element l(4)2C2 (kindly 
provided by J. Kronhamn and A. Rasmuson-Lestander), located 1 kb upstream of the D-Pax2 
transcription start site (Fig. 1).  Molecular characterization of this allele detected a deletion of 
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10 kb uncovering the D-Pax2 promoter and first four exons including the spa enhancer, 
whereas the entire P-element remains intact and inserted at the same site as in l(4)2C2 (Fig. 
1).  Immunostaining of svΔ122 embryos with anti-D-Pax2 antiserum revealed that D-Pax2 
expression in the PNS is completely abolished, whereas its expression in the CNS is not 
affected (Fig. 3A,B).  This confirms that the D-Pax2 gene is transcribed in the CNS from a 
promoter outside the region deleted in the svΔ122 allele.  As the sv enhancer probably remains 
functional in svΔ122 embryos (Shi, 2001), this result further suggests that transcription in the 
PNS depends on the other promoter, the PNS promoter.  Subsequent molecular 
characterization of D-Pax2 transcripts by 5’ RACE confirmed the prediction of another first 
exon in intron 4 whose transcriptional initiation site is located 9729 bp downstream of the 
other transcriptional start site (E. Frei, M. Daube, and M. Noll, unpublished).  This new exon 
is spliced to the old exon 5 of the common downstream region (Fig. 1). 
 
Enhancer-promoter specificity at the D-Pax2 locus 
These results confirm that the sv enhancer activates D-Pax2 transcription from the PNS 
promoter (Fu et al., 1998; Kavaler et al., 1999).  To test whether the sv enhancer is able to 
activate transcription from the other promoter, we performed whole mount in situ 
hybridization to Drosophila embryos with specific probes that cover exons 2-4 (P1), the 
newly discovered first exon transcribed in the CNS (P2), and common downstream exons 
(P3) (Fig. 1).  Probe P1 detected a signal exclusively in the PNS, but none in the CNS (Fig. 
2A), which shows that the probe is specific for PNS transcripts.  This result further excludes 
that the CNS enhancer also activates transcription from the PNS promoter and thus implies 
that transcription in the CNS depends on the other promoter.  By contrast probe P2 produced 
a signal only in the CNS (Fig. 2B), which implies that neither the sv nor the spa enhancer is 
able to activate transcription also from the CNS promoter.  As expected, the probe P3, 
covering common exons, detected signals in the PNS and CNS (Fig. 2C) in a pattern similar 
to the wild-type D-Pax2 expression pattern detected by immunostaining (Fig. 2D).  In 
summary, these results strongly suggest a specificity of the interaction between enhancers 
and their cognate promoters at the D-Pax2 locus.  The sv enhancer specifically activates 
transcription only from the PNS promoter while the CNS enhancer activates only the CNS 
promoter. 
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The sv enhancer is specific for the PNS promoter 
To further validate the sv enhancer specificity for the PNS promoter, a PNS promoter 
deletion allele, sv11A, was generated by imprecise excision of the P-element l(4)2C2 (Fig. 1).  
The molecular characterization of the sv11A allele shows that it contains a deletion of 2.2 kb 
from –1064 bp to +1194 bp, uncovering the PNS promoter and first exon (Fig. 1).  Similar to 
svΔ122 homozygotes, homozygous sv11A animals die as first-instar larvae.  All external sensory 
organs of these larvae appear to be degenerated (data not shown).  Homozygous sv11A 
embryos do not exhibit any detectable D-Pax2 expression in the PNS, whereas its expression 
in the CNS is unaffected (Fig. 3C).  Hence, the CNS transcription unit is intact in the sv11A 
allele (Fig. 1).  In summary, these results demonstrate (i) that the sv enhancer is specific for 
the PNS promoter, and (ii) that this sv enhancer-PNS promoter specificity is not regulated by 
promoter competition, as the sv enhancer does not activate the CNS promoter even in the 
absence of the PNS promoter. 
 
We further confirmed the specificity of the sv enhancer for the PNS promoter by RT-PCR 
analysis of D-Pax2 transcripts in pupal wing discs where D-Pax2 is expressed in the 
developing mechanosensory bristles (Fu et al., 1998; Kavaler et al., 1999).  RT-PCR with 
CNS-specific primers of total RNA isolated from y w early pupal wing discs did not produce 
any product, whereas the product of 380 bp derived from the CNS transcript was observed 
when total RNA from y w embryos was used (Fig. 3E).  By contrast, RT-PCR of total RNA 
from sv11A embryos, in which CNS expression remains unaffected (Fig. 3C), produced the 
expected CNS-specific product (Fig. 3E).  Thus, the absence of CNS-specific transcripts in 
wing discs confirms that the sv enhancer is specific for the PNS promoter and does not 
activate the CNS promoter. 
 
The sv enhancer does not activate the CNS promoter even in close proximity 
Generally enhancers are capable of activating their cognate promoters even if separated by 
large distances.  However, for some enhancers the distance from the promoter is crucial for 
their activation strength (Dillon et al., 1997; Kmita et al., 2002).  Hence, we asked whether 
the distance of 10 kb between the sv enhancer and CNS promoter in the wild type might 
prevent activation of the CNS promoter by the sv enhancer.  To answer this question, we 
analyzed D-Pax2 expression in svΔ122-P embryos.  In the svΔ122-P allele, the sv enhancer and the 
CNS promoter were brought to a distance of 1 kb by precise excision of the P-element in the 
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svΔ122 allele (Fig. 1).  Thus, the svΔ122-P allele contains a 10 kb deletion identical to that of the 
svΔ122 allele, except that the P-element is excised.  In homozygous svΔ122-P embryos, D-Pax2 
expression is not detectable in the PNS, whereas its expression in the CNS remains 
unaffected (Fig. 3D).  This result suggests that the sv enhancer does not activate transcription 
from the CNS promoter, even when they are in close proximity.  We conclude that the sv 
enhancer is specific for the PNS promoter and does not activate the CNS promoter.  In 
addition, the promoter competition mechanism can be excluded in this case to be responsible 
for the enhancer-promoter specificity. 
 
The spa enhancer is specific for the PNS promoter 
Based on our previous work, we knew that the spa enhancer activates transcription from the 
PNS promoter.  The rescue construct, in which D-Pax2 is expressed under the control of the 
spa enhancer and PNS promoter, completely rescues the eye phenotype of spapol flies (Fu and 
Noll, 1997).  We next asked whether the spa enhancer is able to activate D-Pax2 expression 
from the CNS promoter.  In order to answer this question, we took advantage of the PNS 
promoter deletion allele, sv11A.  We reasoned if the spa enhancer is able to activate 
transcription from the CNS promoter, the eye phenotype of sv11A animals should be wild-
type. 
 
However, homozygous sv11A animals die as first instar larvae.  Therefore, these animals were 
rescued to fertile adults by providing the D-Pax2 PNS function through the 6.7-spa 
transgene, which expresses D-Pax2 under the control of a 6.7 kb upstream region of D-Pax2.  
This transgene completely rescues the PNS function but not the eye-specific function of D-
Pax2 (Fu et al., 1998).  These rescued 6.7-spa/+; sv11A flies showed rough eyes similar to the 
spa enhancer deletion allele spapol, although the eye phenotype appeared to be slightly 
rescued (Fig. 4A-C).  This is explained by a low level of expression of D-Pax2 from the 6.7-
spa transgene in the developing eye (Shi, 2001).  Consistent with this explanation, even spapol 
eyes were similarly rescued by the 6.7-spa transgene (Fig. 4D).  Therefore, these results 
suggest that the spa enhancer does not activate the CNS promoter to rescue the eye 
phenotype, even though the spa enhancer is close to the CNS promoter. 
 
It could be argued that the D-Pax2 protein translated from the CNS transcripts is not able to 
rescue the eye phenotype.  However, we consider this possibility very improbable because 
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the spapol allele, which is an in-frame deletion of the coding exons 3 and 4, produces D-Pax2 
transcripts that are functional in the PNS, as evident from spapol flies, and functional in the 
eye, as evident from sv11A/spapol flies (see Chapter 3).  This suggests that the N-terminal part 
of the D-Pax2 protein is not necessary for the PNS and eye functions and hence that the spa 
enhancer cannot activate the CNS promoter.  In addition, we tested the spa enhancer 
specificity for the PNS promoter through a method different from rescue analysis.  If the spa 
enhancer activates transcription from the CNS promoter, CNS-specific transcripts should be 
detectable in eye discs.  To determine this, we performed RT-PCR with CNS specific primers 
and total RNA isolated from eye discs of y w, spapol, and sv11A/spapol third instar larvae.  As 
expected, none of these third instar eye disc RNAs produced any products by RT-PCR, 
whereas total RNA isolated from y w embryos generated a product of the expected size (Fig. 
4E).  This result suggests that the CNS-specific transcripts are not produced in eye imaginal 
discs, which confirms that the spa enhancer does not activate transcription from the CNS 
promoter.  In summary, we conclude that the sv enhancer and the spa enhancer activate 
transcription specifically through the PNS promoter but not the CNS promoter. 
 
Mechanism governing the enhancer-promoter specificity at the D-Pax2 locus 
Thus, neither the sv enhancer nor the spa enhancer are able to activate the CNS promoter.  
This is true even in the absence of the PNS promoter, which suggest that there is no 
competition between these promoters and hence excludes that the promoter competition 
mechanism regulates the enhancer-promoter specificity at the D-Pax2 locus.  Therefore, the 
enhancer-promoter specificity is achieved by one of the remaining two mechanisms, 
illustrated by the enhancer-promoter compatibility or insulator DNA model (Fig. 5).  If an 
insulator DNA is regulating the transcriptional specificity at the D-Pax2 locus, it would serve 
its purpose only in a position upstream of the CNS promoter since it would have to prevent 
the upstream sv and spa enhancers from activating the CNS promoter.  To test whether an 
insulator DNA element is present upstream of the CNS promoter, we used the PlacW 
enhancer trap line, l(4)2C2, that expresses lacZ through a P-element promoter (Bier et al., 
1989).  The LacZ expression pattern of l(4)2C2 embryos, visualized by anti-lacZ 
immunostaining, revealed that it resembles the corresponding D-Pax2 expression pattern in 
the embryonic PNS and CNS (Fig. 6).  In the PNS, most of the LacZ expressing cells co-
localized with D-Pax2 expressing cells (Fig. 6A-D).  This demonstrates that the sv enhancer 
can faithfully activate the nearby P-element promoter in nearly all cells expressing D-Pax2 in 
the PNS.  Similarly, the CNS enhancer can drive LacZ expression through the P-element 
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promoter in the embryonic CNS (Fig. 6E-G).  Many but not all LacZ-expressing cells co-
localized with D-Pax2-expressing cells, which suggests that the CNS enhancer can also 
properly activate the P-element promoter, though not in all cells.  We therefore consider the 
P-element promoter to be ‘promiscuous’.  We have further analyzed the co-localization of D-
Pax2 and lacZ by ImageJ software, which confirmed the co-localization, depicted as white 
pixels in the PNS and the CNS (Fig. 6D,H).  Thus, the CNS enhancer is able to activate the 
P-element promoter, which is located at a distance of more than 20 kb, a region that 
moreover includes several promoters, namely the PNS promoter, the white gene promoter, 
and the CNS promoter (Fig. 1).  This is evident from the fact, that the CNS enhancer is 
outside this region deleted by the sv∆122 allele (s. above).  Thus, these results suggest that both 
the sv enhancer and the CNS enhancer can drive the P-element promoter in a tissue-specific 
fashion.  This observation, however, cannot be explained by the mere presence of an insulator 
upstream of the CNS promoter because of the following arguments.  If the CNS enhancer is 
located downstream of the CNS promoter, it could not have activated the P-element promoter 
in the presence of this insulator.  Even if the CNS enhancer is located upstream of the CNS 
promoter, the presence of insulator cannot explain all results because the CNS enhancer 
would have to act across this insulator to activate its cognate promoter.  A normal insulator 
prevents all enhancers from activating a promoter when located between the enhancer and the 
promoter (Geyer, 1997; West et al., 2002).  Therefore, we exclude the possibility of a normal 
insulator element regulating the enhancer-promoter specificity.  In conclusion, these results 
suggest that it is the compatibility between the enhancers and promoters that determines the 
enhancer-promoter specificity at the D-Pax2 locus. 
 
Promoters rather than enhancers control the enhancer-promoter specificity 
These results clearly demonstrate that the sv enhancer is specific for the PNS promoter and 
the CNS enhancer is specific to the CNS promoter.  Even though these enhancers show 
specificity for their cognate promoters, interestingly, both enhancers activate a promiscuous 
P-element promoter driving lacZ in l(4)2C2.  LacZ expression from l(4)2C2 resembled D-
Pax2 expression in the PNS and CNS.  Therefore, the promoters rather than the enhancers 
regulate the enhancer-promoter specificity at the D-Pax2 locus.  The enhancers regulate the 
tissue-specific transcriptional activation, while the promoters control the enhancer-specificity 
of transcriptional initiation. 
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Discussion 
In the present study, we found enhancer-promoter specificity within a single gene locus, D-
Pax2, regulating its tissue-specific expression pattern.  The D-Pax2 gene is transcribed from 
two different promoters, the PNS promoter and the CNS promoter, in a tissue-specific 
fashion.  Interestingly, the sv enhancer and the spa enhancer activate only the PNS-promoter 
and do not activate the CNS-promoter.  Even though the spa enhancer is close to the CNS 
promoter, it activates only the PNS promoter.  Even the CNS enhancer is specific for its 
cognate CNS promoter and does not activate the PNS promoter, as the shorter D-Pax2 
transcripts were detected only in the CNS.  We have further studied the mechanisms 
regulating this enhancer-promoter specificity at the D-Pax2 locus. 
 
How is the enhancer-promoter specificity achieved has been a fundamental question in the 
study of the transcriptional control of genes.  Previous work has proposed three different 
mechanisms for the regulation of the enhancer-promoter specificity.  Investigating the 
mechanism mediating the enhancer-promoter specificity at the D-Pax2 locus, we have 
excluded the promoter competition mechanism since deletion of the PNS promoter does not 
change the specificity of the sv or spa enhancer in favor of the CNS promoter.  Using the 
PlacW enhancer-trap insertion, we have further ruled out the possibility that a general 
insulator DNA element regulates the enhancer-promoter specificity because the CNS 
enhancer can activate the lacZ gene located upstream of the PNS promoter.  This observation 
cannot be explained by the presence of a normal insulator DNA element that would have to 
be located between them to ensure specificity of the CNS enhancer for its cognate promoter.  
However, we cannot rule out the possibility of a special one-way insulator that would block 
activation by an enhancer in only one direction but not the other.  Such an insulator might 
prevent the upstream sv and spa enhancers from activating the CNS promoter but allow the 
downstream CNS enhancer to activate the upstream P-element promoter.  An insulator with 
this property has not been identified in Drosophila.  In mice, however, such an insulator 
element, called polar silencer, has been reported to be implicated in the transcriptional 
regulation of the HoxD complex (Kmita et al., 2000).  Nevertheless, the presence of a one-
way insulator cannot explain the inability of the CNS enhancer to activate the PNS promoter.  
Therefore, we rule out that an insulator DNA element mediates the enhancer-promoter 
specificity at the D-Pax2 locus.  Taken together, our results suggest that it is the compatibility 
between the enhancer and promoter that mediates the transcriptional specificity at the D-Pax2 
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locus.  We propose that the transcription factors bound to the sv enhancer can only recognize 
the factors bound to the PNS promoter, and similarly that the factors bound to the CNS 
enhancer specifically recognize those bound to the CNS promoter, as in a lock and key 
model. 
 
Our results add another case to previous findings where the intrinsic properties of the 
enhancers and promoters regulate the enhancer-promoter specificity (Li and Noll, 1994; 
Merli et al., 1996).  Our lab has investigated the question of the mechanism by which the 
promoter-enhancer specificity is achieved for the first time and found that it is the 
compatibility between the enhancer and its cognate promoter that ensures transcriptional 
specificity at the closely linked genes of the gooseberry (gsb) and gooseberry neuro (gsbn) 
locus of Drosophila (Li and Noll, 1994).  It has been shown that some enhancers prefer to 
activate TATA box-containing promoters to initiator containing promoters and vice versa 
(Ohtsuki et al., 1998; Butler and Kadonaga, 2001).  We speculate that there might be some 
tissue-specific promoter elements, which are part of these promoters, that would allow only 
transcriptional activation by the corresponding enhancer.  Recently, a promoter-tethering 
element has been reported, located in the promoter region of the Abd-B promoter, that is 
capable of selectively recruiting iab enhancers to the cognate promoter (Akbari et al., 2008).  
Finally, we have demonstrated that promoters rather than the enhancers control enhancer-
promoter specificity, which is in line with the previous findings that core promoter elements 
apart from regulating the transcription initiation also play a significant role in the enhancer-
promoter specificity (Butler and Kadonaga, 2002). 
 
In summary, our data demonstrate that the compatibility between the enhancer and promoter 
mediates the enhancer-promoter specificity at the D-Pax2 locus.  We provide the first 
evidence in Drosophila that enhancer-promoter specificity within a normal gene locus is 
controlled by the core properties of the cis-regulatory elements. 
 
 
Materials and methods 
 
Fly stocks 
The following fly stocks were used.  y w, OreR, sv11A, svΔ122, svΔ122-P, spapol, y w; 6.7-spa (3rd 
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chromosome), y w; l(4)2C2/ciD spapol, and w1118; P{ActGFP}unc-13GJ/sv11A.  A GFP-marked 
4th-chromosome, obtained from the Bloomington Stock Center, stock BL-9549, was used to 
isolate homozygous sv11A embryos. 
 
P-element-generated alleles 
The P element l(4)2C2 is inserted 1064 bp upstream of the D-Pax2 gene (Fig. 2).  The P-
element line was crossed to Δ2–3 to generate excisions.  The male jump-starters were tested 
for complementation with spapol.  The F1 excision lines, which showed a very weak rough 
eye phenotype at the posterior end over the spapol, were selected for further analysis.  The 
molecular nature of these alleles was further analyzed by DNA sequencing of PCR products 
to determine the deletion breakpoints.  The sv11A allele contains a 2.2 kb deletion, from -1064 
bp to +1194 bp, uncovers the entire D-Pax2 PNS promoter and the first exon.  After 
imprecise excision, a 20 bp sequence was inserted at the P-element insertion point. 
 
The svΔ122 allele was generated by imprecise excision of the P-element in l(4)2C2 by a similar 
crossing scheme.  This allele did not complement the spapol allele.  Molecular 
characterization of this allele showed a deletion of 10 kb region whose upstream breakpoint 
is located at the insertion site of the P-element.  This deletion uncovers the PNS promoter, 
exons 1-4 along with the spa enhancer.  This allele contains a reinsertion of the entire P-
element at same location after the imprecise excision.  The svΔ122-P allele was generated by the 
precise excision of the P-element in the svΔ122 allele, screened for lack of the w+ marker.  The 
molecular nature of this allele was determined by PCR, which displayed complete loss of P-
element and a deletion identical to that of the svΔ122 allele. 
 
The generation of svΔ122-P was not trivial, as described by Erich Frei who performed this 
experiment with Michael Daube in our lab.  Surprisingly, svΔ122 flies have white (not even 
weakly red) eyes although the w+ P-element PlacW is still present which became clear only 
after molecular cloning and mapping.  Apparently the w+ gene of PlacW is silenced svΔ122 
flies, whereas it is active and visible as weak w+ eyes in its parent line, l(4)2C2.  When the 
w+ P-element of svΔ122 is mobilized by Δ2–3 P-element transposase, the flies have red-white 
mosaic eyes because in some eye cells the w+ PlacW has jumped and reinserted at other loci 
in the genome where it is not silenced.  Offspring of such flies which still carry the Δ2–3 
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transposase but have white and non-mosaic eyes were candidates for having lost the PlacW.  
The svΔ122-P allele was identified among such candidates. 
 
RNA in situ hybridization 
In situ hybridization to whole mount embryos with DIG-labeled D-Pax2 antisense RNA 
probe was carried out as described (Fu and Noll, 1997). 
 
RNA isolation and semi-quantitative RT-PCR 
Total RNA was isolated from Drosophila embryos (stage 14-17), third instar larval eye discs, 
and wing discs of early white pupae by the use of the "Nucleospin RNA II" kit (Macherey-
Nagel) according to the manufacturer’s instructions.  RT-PCR was performed by the use of 
the One Step RT-PCR kit (Qiagen), following the manufacturer’s protocol.  100 ng of total 
RNA was used for each RT-PCR reaction.  Briefly, RNA was reverse-transcribed for 30 min 
at 50°C, the PCR step was activated by heating for 15 min at 95°C, and the PCR was 
performed for 32 cycles with 1 min denaturation at 94°C, 1 min annealing at 57°C, and 1 min 
extension at 72°C.  The PCR products were analyzed on agarose gels.  The following primers 
were used in the RT-PCR analysis.  D-Pax2 CNS for: 5’-GTTCCGGCATCGATTACAGGT-
3’ (C1 in Fig. 1), D-Pax2 CNS rev: 5’- GACGTGATATGTCACATGGGCGGAC-3’ (C2 in 
Fig. 1).  RpL17A, a constitutively expressed ribosomal protein gene of Drosophila, was used 
as positive control.  RpL17A for: 5’-TGATGAACTGTGCCGACAAC-3’, RpL17A rev: 5’-
TGCATTGGATGCAATACGGG-3’. 
 
Immunohistochemistry and microscopy 
Embryos were fixed and stained as described previously (Fu and Noll, 1997).  The following 
antibodies were used in this study.  Rabbit anti-D-Pax2 antiserum (Fu and Noll, 1997), rabbit 
anti-LacZ polyclonal antibody (Cappel) used at a 1:2000 dilution, and chicken polyclonal 
anti-LacZ antibody (Abcam) used at a 1:250 dilution.  Alexa 488- and Alexa 594-conjugated 
goat secondary antibodies (Invitrogen) were used at a 1:500 dilution.  Biotinylated secondary 
antibodies against rabbit IgG (Vector Laboratories, Inc.) were used at a 1:300 dilution.  For 
the color reaction, Vectastain ABC Kit (Vector Laboratories, Inc.) was used.  Anti-D-Pax2 
staining was enhanced by TSATM kit (Invitrogen).  Microscopy was carried out with a LEICA 
TCS SP confocal microscope.  Images were processed with Adobe Photoshop 7.0 and ImageJ 
software. 
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Scanning electron microscopy 
Pictures of adult fly eyes were taken with a JEOL JSM-6360 LV scanning electron 
microscope.  Female left eyes were pictured at a magnification of 220x. 
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Fig. 2.  Enhancer-promoter specificity at the D-Pax2 locus. 
(A-D) Whole-mount in situ hybridizations of wild-type embryos performed with 
digoxigenin-labeled D-Pax2 antisense RNA probes.  Ventral views of stage 15 embryos, 
oriented with their anterior to the left, are shown.  The D-Pax2 PNS-specific transcripts are 
detected exclusively in the PNS (A).  The D-Pax2 CNS-specific transcripts are detected only 
in the CNS (B).  The D-Pax2 common probe shows signals in the PNS and CNS (C).  
Expression of D-Pax2 determined by staining with the anti-D-Pax2 anti-serum (D). 
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Fig. 3.  The sv enhancer is specific for the PNS promoter of D-Pax2. 
(A-D) Confocal images of Drosophila embryos (stage 16) stained with anti-D-Pax2 
antiserum.  In y w embryos, D-Pax2 expression is detectable in the PNS and CNS (A).  In 
deletion mutant embryos with deletions removing the PNS promoter, D-Pax2 is not 
detectable in the PNS, whereas its expression is detectable in CNS (B-D).  In all panels, 
ventral views are shown with anterior to the left.  (E) RT-PCR analysis of CNS-specific D-
Pax2 transcripts in total RNA isolated from embryos and pupal wing discs. 
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Fig. 4.  The spa enhancer does not activate the CNS promoter. 
(A-D) Scanning electron microscope pictures of eyes of y w (A), y w; spapol (B), y w; 6.7-
spa/+; sv11A (C), and y w; 6.7-spa/+; spapol (D) adults.  (E) RT-PCR analysis of CNS-specific 
D-Pax2 transcripts isolated from embryos and third instar larval eye discs of the indicated 
genotypes. 
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Fig. 6.  The D-Pax2 sv enhancer and the CNS enhancer can activate transcription from 
the P-element promoter. 
Confocal images of l(4)2C2 embryos (stage 15) double-stained with anti-D-Pax2 (red) and 
anti-lacZ (green) antibodies.  (A-D) Lateral views of embryos, displaying the D-Pax2 
expressing cells (red) and LacZ expressing cells (green) in the PNS.  Most of the LacZ 
expressing cells co-localize with the D-Pax2 expressing cells (C).  Co-localization was 
further analyzed by ImageJ software shown as white pixels (D). 
(E-H) Confocal images showing the D-Pax2 expressing cells (red) and LacZ (green) 
expressing cells in the embryonic CNS.  Most of the lacZ expressing cells (F) co-localize 
with the D-Pax2 expressing cells (E).  Co-localization is visualized as overlay of the two 
channels (G) and ImageJ analysis (H). 
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Chapter 3 
 
Enhancer-specific transvection at the D-Pax2 locus of Drosophila 
melanogaster 
 
Summary 
Transvection is a genetic phenomenon observed when complementation of two different 
mutant alleles of a gene depends on chromosome pairing.  In its simplest model, it is 
explained as activation of one promoter by the enhancer of the other allele.  Transvection is 
shown to exist at the D-Pax2 locus.  We have demonstrated for the first time that not all 
enhancers of the D-Pax2 locus are endowed with this property.  The eye-specific sparkling 
(spa) enhancer exhibits transvection, whereas the shaven (sv) enhancer, a PNS-specific 
enhancer, does not.  Our results clearly demonstrate that transvection is specific for the 
enhancer rather than the promoter. 
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Introduction 
In Drosophila homologous chromosomes are always paired in somatic cells (Stevens, 1908; 
Metz, 1916; Fung et al., 1998).  Pairing of homologous chromosomes or regions of 
chromosomes can exert profound effects on gene expression, collectively termed as trans-
sensing effects (Tartof and Henikoff, 1991; Henikoff and Comai, 1998).  Ed Lewis first 
coined the term transvection for the phenomenon of pairing-dependent inter-allelic 
complementation observed at the Ultrabithorax (Ubx) locus of Drosophila (Lewis, 1954).  
Since then transvection has been reported to occur at several genetic loci, including 
Abdominal-B (Abd-B) (Sipos et al., 1998), apterous (ap) (Gohl et al., 2008), decapentaplegic 
(dpp) (Gelbart, 1982), eyes absent (eya) (Leiserson et al., 1994), Salivary gland secretion 4 
(sgs4) (Korge, 1981), Sex combs reduced (Scr) (Southworth and Kennison, 2002), 
Ultrabithorax (Ubx) (Martinez-Laborda et al., 1992), vestigial (vg) (Coulthard et al., 2005), 
yellow (y) (Geyer et al., 1990; Morris et al., 1999), whitespeckled (wsp) (Davison et al., 1985), 
and wings-up A (wup A) (Marin et al., 2004).  Apart from Drosophila, several other 
organisms, including fungi, plants, and mammals, have shown transvection or transvection-
like effects (reviewed in Pirrotta, 1999; Wu and Morris, 1999; Duncan, 2002; Kennison and 
Southworth, 2002; Sipos and Gyurkovics, 2005). 
 
Inter-allelic complementation by trans-sensing effects is observed among three classes of 
alleles, one with mutations in enhancers, another in promoter or coding regions, and a third in 
which an insulator has been inserted between enhancers and promoter.  Transvection studies 
with the y gene have led to two models that explain gene activation in trans that depends on 
the pairing of homologous genes.  In one model, an intact enhancer on one chromosome 
activates transcription from an intact promoter of the intact homologous transcribed region on 
the paired chromosome.  In the other model, pairing with the homologous gene, whose 
enhancer and promoter may be deleted, permits the enhancer to bypass the inserted insulator 
and activate the cognate promoter through a pairing-mediated change in gene structure 
(Morris et al., 1998; Morris et al., 1999).  In addition, it has been demonstrated that the entire 
Drosophila genome is permissive to transvection by the insertion at many locations of 
transgenes, from which either the promoter or the enhancer has been removed by the Cre or 
Flip recombinases (Chen et al., 2002).  Despite considerable progress over the past 50 years, 
the molecular mechanism underlying transvection is not well understood.  The extent of 
somatic homologous chromosome pairing and the general permissiveness of the Drosophila 
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genome to transvection, suggest it to be a general phenomenon.  However, the number of 
genetic loci known to exhibit transvection is low.  This may result from the fact that only for 
few genes enhancer mutations are known that could be tested for complementation with 
structural mutant alleles.  Moreover, whether all or only few enhancers are able to activate a 
paired allele in trans is not known. 
 
Here we demonstrate transvection at the D-Pax2 locus by inter-allelic complementation tests.  
The spa enhancer of D-Pax2 is able to activate in trans, whereas the sv enhancer cannot.  
Since we have shown that both enhancers activate the same of two promoters at this locus 
(see Chapter 2), this finding suggests that transvection is a property of the enhancer rather 
than the promoter.  To our knowledge, this observation is unprecedented since the discovery 
of transvection. 
 
 
Results 
 
Inter-allelic complementation at the D-Pax2 gene locus 
D-Pax2, also known as shaven (sv) or sparkling (spa), encodes a paired-domain containing 
transcription factor (Fu and Noll, 1997; Fu et al., 1998; Kavaler et al., 1999).  During 
Drosophila development, D-Pax2 plays a vital role in the development of adult 
mechanosensory bristles, where it is required for the proper specification and differentiation 
of the shaft and sheath cells (Fu et al., 1998; Kavaler et al., 1999).  In addition, D-Pax2 plays 
an important role in eye development, where it is required for the proper specification and 
differentiation of the primary pigment cells and cone cells (Fu and Noll, 1997; Flores et al., 
2000).  The sv enhancer, which regulates D-Pax2 transcription specifically in the PNS, has 
been mapped to a location upstream of the PNS promoter (Fu et al., 1998; Shi, 2001; Chapter 
2).  The hypomorphic sv alleles shaven-naked (svn) and shaven-depilate (svde), which are both 
insertions of retrotransposons in the sv enhancer, display a strong reduction in bristle size or 
loss of bristles, the sv phenotype (Fig. 1B; Fu et al., 1998; Kavaler et al., 1999).  By contrast, 
the 1.6 kb deletion, spapol, which uncovers the eye-specific spa enhancer as well as the third 
and fourth exons of D-Pax2 (Fig. 2), produces rough eyes, the sparkling (spa) eye phenotype 
(Fig. 1E; Fu and Noll, 1997). 
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In an EMS-induced mutagenesis screen to identify novel genes regulating eye development 
(Casci et al., 1999), two mutations were obtained that mapped to the D-Pax2 locus and were 
kindly given to us by from Tantia Casci.  These D-Pax2 alleles, E67 and E69, are 
homozygous lethal and fail to complement the D-Pax2 hypomorphic alleles svn and svde (Fu et 
al., 1998; Kavaler et al., 1999).  By contrast, transheterozygous svn/E67 flies displayed the sv 
phenotype (Fig. 1C).  Most of the macrochaete bristles on the notum are shaftless, whereas 
the microchaete bristles have reduced shafts.  Sequencing the D-Pax2 coding regions of the 
E67 and E69 alleles showed point mutations generating an early stop codon in the 4th and 7th 
exon, respectively (Fig. 2; Erich Frei, personal communication).  Thus, E67 and E69 are new 
sv point mutation alleles of D-Pax2, svE67 and svE69.  Although these failed to complement the 
sv hypomorphic alleles for the sv phenotype, surprisingly these alleles complemented the 
spapol allele for the spa phenotype.  Thus, svE67/spapol flies showed nearly wild-type eyes (Fig. 
1F).  This inter-allelic complementation can be explained in two ways: (i) the spa enhancer of 
the sv point mutation alleles, svE67 and svE69, activates transcription from the PNS promoter 
on the spapol chromosome in trans, or (ii) the spa enhancer activates transcription in cis from 
the other D-Pax2 promoter, the CNS promoter (Fig. 2). 
 
The spa enhancer exhibits transvection 
To test whether the spa enhancer is able to activate transcription from the CNS promoter in 
cis, we performed RT-PCR analysis of D-Pax2 transcripts produced in third instar eye discs.  
If the spa enhancer is able to activate the CNS promoter, larval eye discs should include 
CNS-specific transcripts of D-Pax2.  In eye discs of third instar sv11A/spapol or y w larvae, no 
CNS-specific D-Pax2 transcripts were detectable (Fig. 4E of Chapter 2).  This shows that the 
spa enhancer cannot activate the CNS promoter and hence suggests that the spa enhancer of 
the sv point alleles activates transcription on the homologous gene in trans, i.e., exhibits 
transvection. 
 
To test whether the spa enhancer is able to activate transcription in trans, we performed a 
complementation test, using promoter-less and enhancer-less D-Pax2 alleles.  The D-Pax2 
promoter deletion allele sv11A was generated by imprecise excision of the P-element insertion 
l(4)2C2, located upstream of the PNS promoter (Fig. 2).  Molecular characterization of sv11A 
allele revealed a deletion of 2.2 kb extending from -1085 bp to +1175 bp relative to the D-
Pax2 PNS transcription start site.  This deletion uncovers the entire D-Pax2 promoter 
including the first exon (Fig. 2).  Similar to the svΔ122 deletion allele, homozygous sv11A 
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animals die as first instar larvae.  These animals can be rescued to fertile adults by the 6.7-spa 
transgene, expressing D-Pax2 under the control of the 6.7 kb upstream region spanning the sv 
enhancer (Fu et al., 1998).  To test the ability of the spa enhancer to support transvection, we 
tried to complement the spa enhancer deletion allele spapol with the promoter deletion allele 
sv11A.  Indeed, the sv11A allele complemented the spapol allele, as sv11A/spapol flies showed 
nearly wild-type eyes (Fig. 3A).  Thus, this inter-allelic complementation test confirms our 
conclusion that the spa enhancer is able to activate in trans.  Moreover, as we have shown 
that the spa enhancer cannot activate the CNS promoter in cis, it follows that the inter-allelic 
complementation between spapol and sv11A resulted only from transvection.  That this 
transvection depends on the spa enhancer is obvious from the rough eye phenotype of the spa 
enhancer-less spapol flies. 
 
The spa enhancer can activate in trans 
D-Pax2 mRNAs produced from the spapol allele in the eye disc are 180 nucleotides shorter 
than those transcribed from the wild-type allele because they lack the third and fourth exon 
(Fig. 2).  Hence, spapol transcripts can be easily distinguished from wild-type transcripts, 
which enables us to identify the chromosome from which D-Pax2 is transcribed.  If inter-
allelic complementation between sv11A and spapol depends on activation by the spa enhancer 
in trans, eye discs of third instar sv11A/spapol larvae are expected to generate D-Pax2 
transcripts only from the spapol chromosome.  To test this, we analyzed D-Pax2 transcripts by 
semi-quantitative RT-PCR of total RNA isolated from third instar eye discs and primers 
located in the 2nd exon (P3) and 5th exon (P4) (Fig. 3B).  Indeed, only spapol-specific 
transcripts were observed in sv11A/spapol eye discs, whereas in controls of y w or spapol eye 
discs only wild-type or no transcripts were detected (Fig. 3B).  These results corroborate at 
the molecular level that the spa enhancer of the sv11A allele only activates its cognate PNS 
promoter that is present in trans on the spapol chromosome.  Therefore, transvection at the D-
Pax2 locus is possible through the spa enhancer. 
 
Activation by spa enhancer shows no preference for promoter in cis 
It has been shown that the body and wing enhancers of the y locus exhibit transvection but 
also a strong preference for the promoter in cis (Morris et al., 2004; Lee and Wu, 2006).  In 
other words, these enhancers activate in trans only in the absence of an intact cognate 
promoter in cis.  Therefore, we wondered whether the spa enhancer exhibits such preference 
for its cognate promoter in cis as well.  To test this, D-Pax2 transcripts produced in spapol/+ 
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eye discs were analyzed by RT-PCR as described above.  In this heterozygous combination 
of the spapol allele, the spa enhancer on the wild-type chromosome is encountered with its 
cognate promoter in cis and another in trans located on the spapol chromosome.  Surprisingly, 
these spapol/+ eye discs produced wild-type and spapol-specific transcripts in about equal 
amounts (Fig. 3B).  This suggests that the spa enhancer on the wild-type chromosome can 
activate transcription from both cognate promoters in cis and in trans.  In summary we 
conclude that, unlike the enhancers of the y gene, the spa enhancer shows no preference for 
its cognate promoter in cis. 
 
The spa enhancer cannot activate in trans when not paired with its promoter 
Classical transvection depends on allelic pairing (Lewis, 1954).  The D-Pax2 gene is located 
on the small 4th chromosome of Drosophila.  Because of its relatively short length, it is 
difficult to disrupt its pairing by translocations.  Nevertheless, we could test the dependency 
of transvection at the D-Pax2 locus on pairing in a spapol background indirectly by a D-Pax2 
transgene that included the spa enhancer.  The D-Pax2 CNS-res-2 transgene (Chapter 4), 
which consists of a 23 kb genomic D-Pax2 fragment extending from, and including, the spa 
enhancer to the next gene downstream of D-Pax2, did not rescue the spapol eye phenotype 
(Fig. 4A).  Similarly, the spa-0.95-lacZ, in which the lacZ coding region is placed under the 
control of the spa enhancer and PNS promoter (Shi, 2001), did not rescue the spapol eyes (Fig. 
4B).  This suggests that the spa enhancer cannot activate its promoter on the 4th chromosome 
in trans when present elsewhere in the genome.  Therefore, to exert transvection the spa 
enhancer has to be in close proximity to the promoter present in trans, as is typical for 
transvection.  Most cases of transvection depend on the normal zeste (z) function (Duncan, 
2002; Kennison and Southworth, 2002).  We have tested whether transvection of the spa 
enhancer also depends on z.  Indeed, sv11A/spapol flies in z mutant background (za or z1) 
showed a rough phenotype in the posterior part of the eye but did not abolish completely 
rescue by transactivation (Fig. 4C,D), which implies that transvection through the spa 
enhancer is only partially dependent on the z function. 
 
The sv enhancer may support transvection at a very low level 
Like the spa enhancer, the sv enhancer activates transcription specifically from the PNS 
promoter (Chapter 2).  Therefore, we tested whether the sv enhancer also supports 
transvection by an attempt to complement the promoter deletion allele sv11A with the 
hypomorphic sv alleles, svde and svn.  If the intact sv enhancer on the sv11A allele is able to 
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activate transcription from the PNS promoter located on svde or svn allele, the sv phenotype 
should be suppressed.  Surprisingly, no complementation was observed although the bristle 
phenotype of sv11A/svde flies is slightly weaker than that of svde flies (Fig. 5A,B), whereas no 
significant difference is observed between the phenotypes of sv11A/svn and svn flies (Fig. 
5C,D).  This suggests that the sv enhancer supports a low level of transvection, much lower 
than that of the spa enhancer, with the PNS promoter.  The fact that this low level of 
transvection is only recognized with the svde, but not the svn, allele is probably explained by 
the accumulation of modifiers in the svn stock, whereas svde mutants cannot be maintained as 
homozygous stock.  Since we cannot rule out that the insertions of retrotransposons in the svn 
and svde alleles prevent pairing with other D-Pax2 alleles and thus transvection, it is possible 
that the sv enhancer of sv11A supports stronger transvection if combined with a sv allele that 
lacks the sv enhancer but not its cognate PNS promoter. 
 
Hence, as for the spa enhancer, we tried to investigate whether the sv enhancer is able to 
support transvection by testing deletion alleles of the PNS promoter or sv enhancer for 
complementation.  To perform this test, a sv enhancer deletion allele, svX14P, was generated 
by imprecise excision of the P-element insertion l(4)2C2 (Fig. 2).  The svX14P allele contains a 
deletion of 1589 bp, from -2982 to -1394, which removes most of the previously mapped sv 
enhancer (Shi, 2001).  Unlike sv11A homozygotes, which show a complete loss of D-Pax2 
function in the PNS and hence die as first instar larvae, 36% of svX14P homozygotes survive to 
adulthood.  However, these flies cannot walk and die soon after eclosion.  Like other 
hypomorphic sv mutants, homozygous svX14P flies displayed a strong sv phenotype (Fig. 6B), 
which implies that most but not all of the sv enhancer is deleted in the svX14P allele.  Most 
macrochaete bristles on the notum lack the shaft structures and instead exhibit double socket 
cells (Fig. 6B).  Transformation of shaft to socket cells is characteristic for the phenotype of 
hypomorphic sv alleles (Kavaler et al., 1999).  Similarly, the microchaete bristles on the 
notum are absent or have greatly reduced shafts (Fig. 6B), as compared to sv+ flies (Fig. 6A), 
while all eye bristles are missing (Fig. 7A,B). 
 
To test whether the sv enhancer deletion allele complements the PNS promoter deletion 
allele, we combined svX14P with sv11A.  If the sv enhancer on the sv11A chromosome is able to 
activate transcription from its cognate promoter on the svX14P chromosome, then these two 
alleles should complement each other.  However, like svde, svX14P did not complement with 
sv11A, but showed a slight rescue of the svX14P bristle phenotype that was more easily 
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recognized when compared to that of hemizygous svX14P/Df(4)G flies (Fig. 6B-D).  Only 31% 
of svX14P/sv11A flies survived and most of them died immediately after eclosion, similar to 
homozygous svX14P flies.  The svX14P/sv11A flies showed a strong sv phenotype (Fig. 6C), very 
similar to that of svX14P flies (Fig. 6B).  The notal macrochaete bristles have no shaft 
structures, and a double socket phenotype is observed (Fig. 6C).  Most of the microchaete 
bristles on the notum showed a minimal increase in length compared to svX14P flies (Fig. 
6B,C).  Also the eye bristles were not rescued (Fig. 7C).  However, one copy of svX14P tested 
over Df(4)G, a large deficiency on the 4th chromosome uncovering the D-Pax2 locus along 
with several neighboring genes (Fu et al., 1998), showed only 7% survival to adults, all of 
which died after eclosion.  These dead flies exhibited a strong sv phenotype (Figs. 6D and 
7D), similar to but stronger than that of svX14P flies (Figs. 6B and 7B).  In conclusion, these 
results demonstrate that PNS promoter deletion allele sv11A does not complement with the sv 
enhancer deletion allele svX14P but slightly rescues the bristle phenotype of svX14P and hence 
seems to support a very low level of transvection. 
 
The sv enhancer may be able to activate in trans at a low level 
To obtain a quantitative measure for the ability of the sv enhancer to activate in trans, we 
relied on quantitative real-time PCR (qPCR) analysis for quantification of PNS-specific D-
Pax2 mRNA levels in embryos (Fig. 8A) and early pupal wing discs (Fig. 8B) of wild-type 
and mutant larvae.  Homozygous or transheterozygous mutant embryos or pupae were 
selected by screening for the absence of a 4th-chromosome marked with actin-GFP.  
Quantitative RT-PCR was performed with total RNA isolated from embryos or white pupal 
wing discs and PNS-specific primers (P1 and P2 in Fig. 2).  As internal controls we have 
quantified the CNS-specific D-Pax2 transcripts in embryos (using C3 and C4 primers in Fig. 
2) and senseless (sens) transcripts in white pupal wing discs.  All reactions were performed 
once (white pupal wing discs) or twice (embryos) in triplicates, and transcript values were 
normalized to transcript levels of three constitutively active genes and set at 1.0 in y w 
embryos or pupal wing discs.  As expected, only background levels of PNS-specific D-Pax2 
transcripts were detectable in sv11A embryos (Fig. 8A).  By contrast, in svX14P embryos the 
level of PNS-specific transcripts was reduced to 39% of that in y w control embryos.  In 
svX14P/sv11A embryos, the level of PNS-specific mRNA was reduced to 31%, which is only 
5% above that of hemizygous svX14P/Df(4)G embryos (Fig. 8A).  Thus, the PNS-specific D-
Pax2 mRNA level in svX14P/sv11A embryos is only slightly higher than that produced by one 
copy of svX14P, which confirms that transvection contributes relatively little to D-Pax2 levels 
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in the PNS of svX14P/sv11A embryos.  Similarly, we have measured D-Pax2 mRNA levels in 
white pupal wing discs.  Surprisingly, here D-Pax2 transcript levels were about two fold 
higher in svX14P/sv11A than in svX14P/Df(4)G discs (Fig. 8B).  However, contrary to what is 
expected discs with two copies of svX14P show lower transcript levels than discs with one 
copy in svX14P/Df(4)G white pupae (Fig. 8B).  This result casts doubt on the precision by 
which these transcript levels can be measured by this method.  A more reliable, though not 
quantitative, test therefore is the bristle phenotype.  We conclude that the sv enhancer is able 
to activate in trans minimally which, unlike the spa enhancer, is not sufficient to rescue the 
survival and the sv phenotype in complementation tests. 
 
Finally, we have tested whether the expression pattern of D-Pax2 in the embryonic PNS can 
be rescued by the sv enhancer acting in trans.  D-Pax2 is expressed in the developing PNS, 
which includes all developing external sensory organs and the chordotonal organs (Fig. 9A; 
Fu et al., 1998; Kavaler et al., 1999).  As expected, D-Pax2 expression is completely 
abolished in the PNS of sv11A embryos (Fig. 9B), whereas in svX14P embryos, the number of 
D-Pax2 expressing cells is reduced compared to wild-type embryos (Fig. 9A,C).  Clearly, the 
lateral chordotonal cell clusters do not express D-Pax2 in svX14P embryos (Fig. 9C).  
Similarly, svX14P/sv11A embryos fail to express D-Pax2 in chordotonal organs, and the PNS 
expression pattern is similar to that of svX14P embryos (Fig. 9D).  Thus, these results suggest 
that the sv enhancer cannot rescue expression in the embryonic PNS by activation of D-Pax2 
in trans, although small effects cannot be ruled out.  We conclude that, in contrast to the spa 
enhancer, the sv enhancer may support transvection only at a very low level.  Therefore, 
transvection is a quantitative property of the enhancer. 
 
 
Discussion 
In the present study, we report a new example of transvection in Drosophila at the D-Pax2 
locus.  We found that the spa enhancer of D-Pax2 supports transvection to the extent that the 
eye phenotype is rescued solely by transvection, whereas the sv enhancer of the same locus is 
unable to rescue the sv phenotype by transvection, which suggests that transvection is an 
enhancer-specific phenomenon.  Thus, two different tissue-specific enhancers of a single 
gene locus, activating the same cognate promoter in cis, exhibit contrasting abilities to 
activate in trans.  Hence, this property is enhancer- rather than promoter-specific. 
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We have shown that the deletion allele of the spa enhancer complements that of the PNS 
promoter.  Therefore, the inter-allelic complementation results from the ability of the spa 
enhancer to activate a promoter in trans, as proposed for transvection of the y gene (Morris et 
al., 1998; Morris et al., 1999).  Taking advantage of the shorter D-Pax2 transcripts of the 
spapol allele, we have shown that the spa enhancer is able to activate transcription from its 
cognate promoter in cis as well as in trans.  This is different from the y gene, where the body 
and wing enhancers show a strong preference for a promoter in cis to one in trans.  Our 
results, however, are consistent with a previous report (Goldsborough and Kornberg, 1996).  
In addition, these authors demonstrated that the chromosomal pairing stimulates transcription 
in both cis and trans because disruption of pairing leads to a decrease in transcription of both 
alleles (Goldsborough and Kornberg, 1996). 
 
The sv enhancer deletion allele, svX14P, failed to complement the PNS promoter deletion 
allele, sv11A, for survival and bristle phenotype although a low level of transvection was 
detectable.  Similarly, quantitative measurements of the D-Pax2 transcripts revealed that the 
sv enhancer is able to show weak activation in trans.  We propose that the non-
complementation between the sv enhancer deletion allele and the PNS promoter deletion 
allele results from insufficient D-Pax2 transcript levels produced through enhancer trans-
activation.  By contrast, in the case of transvection by the spa enhancer, D-Pax2 transcript 
levels produced in trans are sufficient to rescue the eye phenotype in inter-allelic 
complementation tests.  Thus, the ability to support transvection depends on the quantitative 
property of the enhancer.  In summary, our data strongly suggest that transvection is a 
property of the enhancer but not of the promoter because only one of two different enhancers 
activating the same promoter in cis can activate it also in trans.  Hence transvection at the D-
Pax2 locus depends on the property of the individual enhancer. 
 
 
Materials and methods 
 
Fly stocks 
The following fly stocks were used.  y w, svn, svde, ciD spapol, Df(4)G (Fu, et al., 1998), svΔ122 
(Shi, 2001), svΔ122-P, svE67, svE69, sv11A, svX14P, spa-0.95-lacZ (Shi, 2001), l(4)2C2 (kindly 
provided by J. Kronhamn and A. Rasmuson-Lestander), za, z1 (stocks BL-1059 and BL-200 
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from Bloomington Stock Center), P{ActGFP}unc-13GJ (GFP-marked 4th-chromosome, stock 
BL-9549 from Bloomington Stock Center). 
 
Generation of D-Pax2 mutants 
The D-Pax2 alleles sv11A, svΔ122, svΔ122-P were generated by imprecise excisions of P-elements 
(see Materials and methods of Chapter 2).  The sv enhancer deletion allele, svX14P, was 
generated by imprecise excision of the w+ PlacW P-element insertion l(4)2C2 (Fig. 1).  The 
animals in which the P-element is mobilized with the Δ2–3 P-element transposase (w; TMS, 
P{Δ2-3}99B/+; l(4)2C2/spapol) were crossed to spapol/ciD spapol flies.  F1 males with spa+ but 
white eyes of the genotype w; TMS, P{Δ2-3}99B/+; ex(4)2C2/ciD spapol were crossed to 
Df(4)G/ciD spapol virgins.  In these males the P-element has been excised and not only its w+ 
marker silenced, as silenced w+ markers would result in red mosaic eyes because of the 
continued presence of the P-element transposase.  In 7 out of over 100 such males the P-
element had not excised cleanly because they produced no ex(4)2C2/Df(4)G offspring.  
Rather the excision created a lethal PNS expression mutation of D-Pax2 at or near the 
original P-element insertion site, which is uncovered by the deficiency Df(4)G, which also 
deletes neighboring genes (Fu et al., 1998).  The lethal excisions could delete the D-Pax2 
PNS promoter and/or the sv enhancer, but not also the spa enhancer since the F1 males were 
spa+, as are their ex(4)2C2/ciD spapol offspring used to establish the 7 stocks, in two of which 
the mutation was characterized in detail.  One allele, svX4P is a PNS promoter deletion smaller 
than in sv11A (Fig. 2).  The svX14P allele is a 1589 bp deletion from -2982 to -1394 upstream of 
the PNS transcription initiation site, which surprisingly is 328 bp upstream of the original P-
element insertion site and thus deletes more than the sv enhancer mapped by lacZ reporter 
genes and sv rescue transgenes (Shi, 2001).  In addition, the PlacW was deleted during 
mobilization except for 16 bp at its left and 13 bp at its right end.  In other words, 29 bp of 
the inverted repeat DNA and 8 bp target site duplication (in total 45 bp) are located between -
1065 and -1074. 
 
RNA isolation 
Total RNA was isolated from Drosophila embryos, the eye part of eye-antennal discs of 
wandering third instar larvae, and white pupal wing discs of wild type and D-Pax2 mutants.  
To recognize homozygous or transheterozygous sv mutants during development, a GFP-
marked, P{ActGFP}unc-13GJ, 4th chromosome was used as balancer chromosome.  Total 
RNA was isolated with Nucleo Spin RNA II (MACHEREY NAGEL) kit according to the 
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manufacturer’s instructions. 
 
Semi-quantitative reverse transcription polymerase chain reaction (RT-PCR) 
All enzymatic reactions of RT-PCR were performed with 100 ng of total RNA isolated from 
eye discs with the One Step RT-PCR kit (Qiagen) in one tube.  After reverse transcription, in 
which first strand cDNA is primed and synthesized with the specific reverse primer for 30 
min at 50°C, the HotStarTaq DNA polymerase is activated for 15 min at 95°C.  
Subsequently, 32 PCR cycles are performed with 1 min denaturation at 94°C, 1 min 
annealing at 57°C, and 1 min extension at 72°C.  The last cycle is followed by a 10 min 
incubation at 72°C.  The DNA products were analyzed on 1.5% agarose gels.  The following 
primers were used in RT-PCR reactions. 
D-Pax2 PNS forward (P3): 5’-GATATACAGACATCGACACATC-3’, 
D-Pax2 PNS reverse (P4): 5’-GACGTGATATGTCACATGGGCGGAC-3’. 
PCR reactions with RpL17A, a constitutive ribosomal protein gene in Drosophila that was 
used as loading control, used the following primers: 
RpL17A forward: 5’-TGATGAACTGTGCCGACAAC-3’, 
RpL17A reverse: 5’-TGCATTGGATGCAATACGGG-3’. 
 
Quantitative real-time polymerase chain reaction (qPCR) 
First-strand cDNA was primed with oligo-dT primer on 0.5 µg of total RNA and synthesized, 
according to the manufacturer's instructions, by the use of the SuperScript™ III First-strand 
synthesis kit for RT-PCR (Invitrogen).  The generated cDNA pools were used as templates 
for PCR reactions performed in triplicates for each primer pair.  The products were quantified 
with an ABI 7900HT sequence detection apparatus, which measures the amount of double 
stranded DNA with SYBR Green fluorescence after every PCR cycle.  PCR reactions were 
made with kits from either ABI (Power SYBR Green PCR Master Mix) or Eurogentech 
(MESA GREEN qPCR MasterMix Plus).  Normalization was based on the transcript levels 
of three constitutively expressed genes, actin5C, TBP (TATA-binding protein gene), and α-
tubulin, in all the RNA samples from the different genotypes.  The following primers were 
used in qPCRs. 
D-Pax2 PNS forward (P1): 5’-CAGGGCAGTATTTCGGGTGAT-3’, 
D-Pax2 PNS reverse (P2): 5’-GTGGGCGACCATTAACGAAT-3’, 
D-Pax2 CNS forward (C1): 5’-AACCAGAACATGATGGAATACTACACAT-3’, 
D-Pax2 CNS reverse (C2): 5’-TGGGCGACCATTAACGAATAC-3’, 
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sens forward: 5’-CCAATATTGTGGCAAGCGGT-3’, 
sens reverse: 5’-GGTGCACTTGTGTGGCTTCT-3’, 
actin5C forward: 5’-GCCCATCTACGAGGGTTATGC-3’, 
actin5C reverse: 5’-AATCGCGACCAGCCAGATC-3’, 
TBP forward: 5’-CGCGCATCATCCAAAAGC-3’, 
TBP reverse: 5’-GCCGACCATGTTTTGAATCTTAA-3’, 
α-tubulin forward: 5’-GCCAGATGCCGTCTGACAA-3’, and 
α-tubulin reverse: 5’-AGTCTCGCTGAAGAAGGTGTTGA-3’. 
 
Immunohistochemistry and microscopy 
Embryos were fixed and stained as described previously (Fu and Noll, 1997).  Rabbit anti-D-
Pax2 antiserum was used as described (Fu and Noll, 1997).  Anti-D-Pax2 staining was 
enhanced by the use of a TSATM kit (Invitrogen).  Confocal microscopy was carried out with 
a LEICA TCS SP microscope.  Images were processed with Adobe Photoshop 7.0 and 
ImageJ software. 
 
Scanning electron microscopy of adult eyes and nota 
Flies are killed by exposure to ether vapors for 5 min and mounted untreated in a JEOL JSM-
6360 LV scanning electron microscope.  After at least one minute in the vacuum chamber, 
micrographs of eyes were taken at 220x magnification and of nota at 100x or 85x 
magnification. 
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Fig. 1.  Interallelic complementation at the D-Pax2 locus. 
(A-F) Scanning electron micrographs of notum and scutellum (A-C) and of compound eyes 
(D-F) of y w (A,D), svn (B), svn/svE67 flies (C), spapol (E), and svE67/spapol (F) flies. 
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Fig. 3.  The spa enhancer of D-Pax2 exhibits transvection. 
(A) Scanning electron micrographs of left eye of sv11A/spapol fly.  (B) Semi-quantitative RT-
PCR analysis of D-Pax2 transcripts produced from total RNA of 3rd instar larval eye discs.  
The relevant portions of 1.5% agarose gels illustrating the DNA bands produced by RT-PCR 
from total RNA of eye discs of indicated genotypes are shown.  Below, the D-Pax2 exons 
spanned by the PCR reaction with primers P3 and P4 of y w and spapol DNA are indicated. 
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Fig. 4.  Transvection by the spa enhancer depends on paired alleles and partially on the 
function of zeste. 
(A-D) Scanning electron micrographs of CNS-res-2/+; spapol (A), spa-0.95-lacZ/+; spapol 
(B), z1; sv11A/spapol (C), za; sv11A/spapol (D) adult left eyes. 
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Fig. 5.  The promoter deletion allele, sv11A, complements the classical sv enhancer 
insertion alleles, svde and svn, at most very little. 
(A-D) Scanning electron micrographs of notum and scutellum of svde (A), svde/sv11A (B), svn 
(C), and svn/sv11A (D) flies. 
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Fig. 6.  The promoter deletion allele, sv11A, complements the deletion allele of the sv 
enhancer, svX14P, for body bristle formation at most very little. 
(A-D) Scanning electron micrographs of notum and scutellum of y w (A), svX14P (B), 
svX14P/sv11A (C), and svX14P/Df(4)G (D) flies. 
 
 
 60 
 
 
Fig. 7.  The promoter deletion allele, sv11A, does not complement the deletion allele of the 
sv enhancer, svX14P, for eye bristle formation. 
(A-D) Scanning electron micrographs illustrating the bristle phenotype of y w (A), svX14P (B), 
svX14P/sv11A (C), and svX14P/Df(4)G (D) eyes. 
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Fig. 8.  Quantitative real-time PCR analysis of D-Pax2 transcripts. 
(A,B) qPCR analysis of reverse transcribed PNS-specific transcripts in embryos (A) and 
white pupal wing discs (B) of genotypes indicated.  Error bars represent standard deviations. 
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Chapter 4 
 
The role of D-Pax2 in the developing CNS of Drosophila 
 
Summary 
D-Pax2, also known as sparkling (spa) or shaven (sv), encodes a paired-domain containing 
transcription factor.  While its function in the developing eye and peripheral nervous system 
have been described, little attention was payed to its expression in the developing central 
nervous system.  Here we have started to analyze the CNS function of D-Pax2.  Using 
generated D-Pax2 null alleles, we have shown that loss of function in the CNS is lethal.  In 
addition, a conserved enhancer element regulating transcription in the CNS has been mapped 
to the 6th intron of D-Pax2. 
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Introduction 
D-Pax2 encodes a highly conserved paired-domain containing transcription factor closely 
related to the vertebrate Pax2, Pax5, and Pax8 subfamily (Fu and Noll, 1997; Fu et al., 1998).  
The mammalian Pax2 gene plays important roles in the development of the ear, eye, kidney, 
and brain (for review, see Noll, 1993; Dahl et al., 1997).  Similarly, D-Pax2 is required for 
the proper development of eyes (Fu and Noll, 1997), Johnston's organ, the Drosophila ear, 
and mechanosensory bristles (Fu et al., 1998; Kavaler et al., 1999).  Like its mammalian 
counter part, D-Pax2 is also expressed in the developing CNS (Fu and Noll, 1997), which 
suggests a role for D-Pax2 in CNS development. 
 
The Drosophila CNS is a complex organ and serves as an ideal system to study 
developmental processes such as cell determination, specification, and differentiation 
(Urbach and Technau, 2004).  The Drosophila CNS develops from a bilateral neuroectoderm 
that lies on each side of a narrow strip of ventral midline cells.  Neuroectodermal cells 
delaminate from the surface epithelium and move into the interior of the embryo to form a 
neural precursor cell, called neuroblast (Campos-Ortega and Hartenstein, 1985; Doe, 1992).  
A neuroblast divides asymmetrically to give rise to a neuroblast and a ganglion mother cell, 
which subsequently divides once to produce a differentiating neuron or glial cell.  The 
position of each neuroblast in the developing CNS specifies the type of neurons and glial 
cells it produces (Chu-LaGraff et al., 1995; Broadus et al., 1995; Bossing et al., 1996a,b).  
Two classes of genes regulate the selection and delamination of neuroblasts: proneural genes 
promote neuroblast formation in a proneural cluster of ectodermal cells, one of which is 
selected fortuitously to become the neuroblast that prevents the remaining cells of the cluster 
from adopting also a neuroblast fate by the activity of the neurogenic genes, a process called 
lateral inhibition.  The identification of genes controlling the development of the CNS and the 
characterization of their molecular functions in cell fate determination and differentiation has 
provided new insights into the problem of how neuronal diversity is generated (Urbach and 
Technau, 2004). 
 
Here, we have shown that D-Pax2 plays an important role in the developing CNS, as its CNS 
function is required for development to adulthood.  We have mapped the enhancer of this 
function, previously shown to activate a separate promoter of D-Pax2. 
 
 65 
Results 
The function of D-Pax2 in the CNS is vital for development 
After the identification of the CNS promoter of D-Pax2 (Chapter 2), it became possible to 
study the role of D-Pax2 in the CNS separately from its other functions that rely on 
transcription from the PNS promoter governed by the sv and spa enhancers.  To characterize 
the phenotype of animals lacking D-Pax2 expression in the CNS, CNS-specific mutant alleles 
would be highly desirable.  Since this could be achieved by the rescue of D-Pax2 null alleles 
with the PNS function of D-Pax2, we decided to generate such null alleles, again using 
imprecise excision of the P-element l(4)2C2.  Five excisions generated null alleles, two of 
which were characterized in detail.  In both null alleles, sv12 and sv14, a large region is 
deleted, extending from the insertion site of the P-element upstream of the PNS promoter to 
beyond the CNS promoter (Fig.1).  The sv12 deletion spans 17,726 bp, ending in intron 6.  In 
sv14 the deletion extends over 26,974 bp into the 3’ flanking region and hence removes more 
than the entire transcribed region (Fig. 1).  Not surprisingly, no D-Pax2 expression was 
detected by anti-D-Pax2 immuno-staining in homozygous sv12 and sv14 embryos (Fig. 2A-C).  
In addition, sv12/spapol and sv14/spapol flies show rough eyes, as expected (Fig. 3).  Like svΔ122 
homozygotes, which lack expression only in the PNS, sv12 and sv14 larvae have no external 
mechanosensory organs and die during the first instar.  Therefore, up to this lethal phase, 
additional loss of CNS expression does not result in an observably more severe phenotype.  
To assess the function of D-Pax2 in the CNS later in development, we added the 6.7-spa 
transgene (Fu et al., 1998) to sv12 and sv14 homozygotes.  This transgene provides the D-Pax2 
PNS function since it was shown to rescue the lethality of animals lacking PNS expression, 
i.e., of sv11A and svΔ122 homozygotes (Shi, 2001).  No 6.7-spa/+; sv12 or 6.7-spa/+; sv14 
animals survived to adulthood.  However live, normal looking second instar and much fewer 
third instar larvae, but no pupae, were found.  We conclude that expression of D-Pax2 in the 
CNS is vital for larvae to develop beyond the first instar.  In the following we will show that 
these animals that lack only the CNS functions of D-Pax2 will also be helpful in the search of 
transgenes complementing the missing CNS functions. 
 
Genomic region of D-Pax2 required for CNS function 
Previous attempts to find the CNS enhancer of D-Pax2 tested lacZ reporter genes under the 
control of a CNS promoter, extending 300 bp upstream of the transcription start, for 
expression in the embryonic CNS.  However, transgenes combining various potential 
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enhancer fragments downstream of the svΔ122 deletion (Fig. 1) with this reporter gene showed 
no embryonic expression (Wälchli, 2003).  This negative result can be explained in several 
ways: (i) the enhancer of interest is not located in the regions tested, (ii) the enhancer was 
fragmented and thus inactivated by the choice of the regions tested, or (iii) the promoter 
region selected is not sufficiently large for activation by the CNS enhancer.  Homozygous 
svΔ122-P embryos exhibit a D-Pax2 expression pattern in the CNS that is similar, if not 
identical, to that of wild-type embryos (Fig. 3A,B of Chapter 2).  This result excludes the 
CNS enhancer from the region deleted by svΔ122-P.  To determine whether the CNS enhancer 
is located upstream or downstream of the PNS promoter, two D-Pax2 alleles, generated by 
imprecise excision of the P-element of the l(4)2C2 insertion were very helpful.  These alleles, 
sv26.2 and sv51.1, delete a large genomic region, encompassing D-Pax2 and several downstream 
genes, but not the upstream region spanning the sv enhancer and the PlacW insertion, which 
remains at the same location as in l(4)2C2 (Fig. 1).  LacZ expression of l(4)2C2 embryos 
suggested that both the sv enhancer and the CNS enhancer can activate the P-element 
promoter driving the lacZ gene (Fig. 4A).  By contrast, in sv26.2 and sv51.1 embryos LacZ 
expression was detectable only in the PNS but not the CNS (Fig. 4B,C), which suggests that 
the deleted region contains an essential part of the CNS enhancer whereas the upstream 
region does not contain the CNS enhancer.  To further narrow down the region harboring the 
CNS enhancer, a genomic rescue construct, D-Pax2 CNS-res, was prepared.  It consisted of a 
23 kb genomic fragment that spanned the entire region transcribed in the CNS, extending 
from the spa enhancer to the middle of the neighboring downstream gene, calsyntenin-1, 
which is transcribed in opposite direction (Fig. 1).  Two out of three lines were able to rescue 
the D-Pax2 CNS null animals to fertile adults.  Moreover, D-Pax2 expression in the CNS was 
rescued, though at reduced levels (Fig. 2D).  Therefore, the CNS enhancer is included in the 
23 kb of this D-Pax2 transgene. 
 
A conserved CNS enhancer element in intron 6 of D-Pax2 
LacZ expression in the CNS of embryos of the PlacW enhancer trap line l(4)2C2 suggested 
that the CNS enhancer of D-Pax2 is able to activate lacZ under control of the P-element 
promoter from a position downstream of lacZ (Fig. 1).  Therefore, we combined a lacZ 
reporter gene (Fig. 6A), similar to PlacW (Bier et al., 1989), with D-Pax2 DNA fragments to 
be tested for CNS enhancer activity and inserted downstream of lacZ.  Two such fragments 
were chosen on the basis of the following considerations.  Since functional cis-regulatory 
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elements tend to be conserved between closely related species (Kellis et al., 2003, Chan et al., 
2005, Elemento and Tavazoie, 2005), we compared the D-Pax2 DNA sequence with that of 
five other Drosophila species, using the Genome Vista comparison program (Frazer et al., 
2004).  The VISTA graph indicates where the conservation between the aligned D-Pax2 
sequences is above 50% (Fig. 5).  Regions exhibiting more than 75% of conservation in all 
Drosophila species examined have been considered to harbor conserved functions.  These 
include the coding exons (dark blue regions in Fig. 5) and all known regulatory regions, i.e., 
the PNS promoter, the sv enhancer, and the spa enhancer.  Interestingly, there is also high 
conservation at the CNS promoter, which suggests that the use of this CNS-specific 
transcription initiation site has been conserved in the other Drosophila species as well.  In 
addition, a high degree of conservation is observed in sequences of the 6th intron, which thus 
is a good candidate to include the CNS enhancer.  Hence we selected the 2.5 kb of the 6th-
intron to be tested for CNS enhancer activity.  In addition, the 1.8 kb downstream intergenic 
region was tested because this region had not been examined in previous attempts to map the 
CNS enhancer (Wälchli, 2003). 
 
The ability of these regions to drive lacZ expression in the CNS was tested by inserting these 
fragments at a position downstream of lacZ into the PlacW8 vector (Fig. 6A) that was 
subsequently used for germline transformation.  In transgenic embryos, the lacZ gene under 
the control of the 6th-intron was expressed in the CNS in a pattern similar to that of D-Pax2 
(cf. Fig. 6B-E with Fig. 2A,D).  By contrast, when it was under the control of the downstream 
intergenic region, it was not expressed in the CNS (Fig. 6F,G).  These results suggest that the 
CNS enhancer is indeed included in the conserved region of the 6th intron. 
 
The enhancer in the 6th intron can drive D-Pax2 expression in the CNS 
If the 6th intron contains the CNS enhancer, it should be able to activate transcription from its 
cognate promoter, the CNS promoter.  To test this, we have generated D-Pax2-CNS-lacZ 
reporter constructs under the control of the 6th intron, which was positioned upstream or 
downstream of the CNS promoter.  Two versions of CNS promoters were used, one 
extending 760 bp, the other only 300 bp upstream of the start site for CNS-specific 
transcripts.  The unusually large promoter extending to -760 bp was chosen because it 
includes the entire upstream sequence present in svΔ122-P embryos (Fig. 1), which display a 
wild-type D-Pax2 expression pattern in the CNS (Fig. 3D of Chapter 2) and hence must 
include the CNS promoter.  The alternative CNS promoter extending to -300 bp was used 
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because it had been used in earlier, though unsuccessful, attempts to localize the CNS 
enhancer.  The D-Pax2-CNS-lacZ constructs without enhancer served as control.  All lines of 
the transgene under control of the -760 bp promoter and the 6th intron cloned upstream of it 
showed LacZ expression in the embryonic CNS (Fig. 7B).  Double labeling with anti-LacZ 
and anti-D-Pax2 shows that most cells that express LacZ also express D-Pax2 (Fig. 8).  
However, the 6th intron did not reproduce the complete CNS expression pattern of D-Pax2 
(Fig. 8), which suggest that the 6th intron might not comprise the complete CNS enhancer.  
When the 6th intron was inserted downstream of lacZ in the transgene with the -760 promoter, 
the LacZ expression pattern in the CNS was similar but much weaker (data not shown).  By 
contrast, lacZ transgenes under control of the -300 bp promoter and the 6th intron did not 
exhibit any detectable LacZ expression in the embryonic CNS (data not shown).  These 
results suggest that the -300 bp CNS promoter region does not comprise the complete 
promoter, which would explain the failure of previous attempts with lacZ reporter genes that 
included only 300 bp upstream of the CNS transcriptional start site to map the CNS enhancer.  
The control D-Pax2-CNS-lacZ transgenes without the 6th intron did not show any expression 
of LacZ in the developing embryonic CNS (data not shown).  In summary, these results 
demonstrate that the 6th intron of D-Pax2 contains an enhancer capable of driving expression 
in the CNS and that a functional CNS promoter must extend beyond 300 bp, but is included 
in 760 bp, upstream of the CNS-specific transcriptional start site. 
 
Mapping the CNS-specific transcription initiation site by S1-nuclease 
The unusually large CNS promoter raised the question of whether the 5’RACE method did 
correctly determine the transcriptional start site of this promoter, as an initiation site located 
further upstream would reduce the size of the CNS promoter.  Therefore, it was attempted to 
determine the initiation site by the independent method of S1-nuclease mapping.  As argued 
above, the true transcriptional start site is less than 760 bp upstream of that determined by 
5’RACE.  Hence, a region extending from – 760 to + 70 was chosen for S1-nuclease 
mapping of the transcription initiation site.  Four probes of 100 nt length each were selected 
from this region (P1-P3 and P5 in Fig. 9A), hybridized to total RNA before digestion with 
S1-nuclease, and the protected 5’ labeled probes analyzed on a gel (Fig. 9B).  A 70 nt 
fragment of probe P1, originally extending from -31 to +69, was protected (arrowhead in Fig. 
9B).  This fragment correlates precisely with the initiation site determined by 5’RACE.  In 
addition, a fragment at 65 bp was observed, which might result from slightly degraded 
mRNA or an alternative initiation site, located 5 bp downstream.  The other three probes, 
 69 
covering overlapping upstream sequences or a sequence around -760, were not protected 
against S1-nuclease digestion after hybridization to total RNA (Fig. 9B).  Interestingly, all 
probes showed a weak complete protection, which results from hnRNA transcribed from the 
PNS promoter that still includes this portion of intron 4.  S1-protection experiments with total 
RNA from 6.7-spa/+; svΔ122-P embryos and probes P1-P3 showed similar results to those 
from y w embryos (Fig. 9B).  However, probe P5 was still present in small amounts as intact 
fragment (lane 8 in Fig. 9B) and as a much shorter fragment of about 78 nt.  This fragment is 
consistent with the presence of RNA transcribed across the breakpoint of the svΔ122-P deletion.  
In addition, these digests apparently suffered from slightly incomplete S1-digestion, as 
evident from the presence of small amounts of intact probes.  In agreement with these 
interpretations, control experiments with human RNA did not protect any probe (lanes 9-12 
in Fig. 9B).  We conclude that there is no initiation site of CNS-specific transcripts different 
from that previously determined by 5’RACE. 
 
D-Pax2 transgene driven by the CNS enhancer of intron 6 rescues the lethality of 
animals that lack D-Pax2 expression in the CNS 
To test whether the lethality of animals lacking D-Pax2 expression in the developing CNS 
can be rescued by D-Pax2 expression regulated by the CNS enhancer element of intron 6, 
two CNS-specific D-Pax2 transgenes were constructed, one with cDNA into exon 9 and 
genomic DNA downstream of exon 9, the other with a cDNA lacking exons 10 and 11 and 
genomic DNA downstream of exon 12, both under the control of the CNS promoter and 
intron 6.  The shorter transgene was chosen because the analysis of CNS-specific D-Pax2 
transcripts of wild-type embryos by RT-PCR displayed one most abundant transcript, in 
which exon 9 is spliced to exon 12 (Fig. 1).  Interestingly, both transgenes rescue 6.7-spa/+; 
sv14 animals to adulthood.  However, the rescue efficiency of a single copy of each transgene 
is only about 50%.  Since CNS expression of D-Pax2 in these embryos endowed with only 
one copy of one of these transgenes was not detectable, it is not clear whether the reduced 
rescue efficiency results from an incomplete CNS enhancer in intron 6 or from a position 
effect on the transgene in the lines tested.  The rescued flies are weak but did not show any 
visible morphological defects.  Preliminary tests suggest that males and/or females are sterile 
because stocks could not be established.  In conclusion, these results demonstrate that intron 
6 contains an important part of the D-Pax2 CNS enhancer, which may require other elements 
important for complete rescue of the CNS function. 
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Discussion 
It is known that D-Pax2 function in the PNS is vital for Drosophila development to 
adulthood (Shi, 2001).  In the present study, we have shown that D-Pax2 also plays a vital 
role in the development of the CNS.  D-Pax2 loss-of-function in the CNS is lethal during 
larval stages.  At least one copy of the D-Pax2 CNS gene is necessary for development to 
adulthood.  Previously, the mammalian Pax2 gene has been shown to play a role in CNS 
development (for review, see Noll, 1993; Dahl et al., 1997).  Our study thus seems to imply 
that, in addition to the PNS and eye functions, D-Pax2 function in the CNS is conserved from 
Drosophila to humans.  Hence, future studies on the function and regulation of D-Pax2 in 
CNS development of Drosophila might improve our understanding of Pax2 functions in 
development and diseases of the higher animals. 
 
D-Pax2 is transcribed from two different promoters in a tissue-specific manner.  The sv 
enhancer and the spa enhancer specifically activate transcription from the PNS promoter, 
whereas the CNS promoter is specifically activated by the CNS enhancer, which suggests 
that D-Pax2 transcription in the CNS is probably regulated by tissue-specific promoter 
factors (Chapter 2).  Tissue-specific use of more than one transcription initiation site has been 
reported for crystallin genes (van Leen et al., 1986).  The recruitment of these tissue-specific 
promoter-binding factors may direct RNA polymerase II to initiate transcription at their 
promoter.  Moreover, since the CNS promoter and the CNS-specific first exon are highly 
conserved among Drosophila species, the use of an alternative promoter in the CNS has 
probably been conserved during evolution. 
 
The genomic rescue construct containing the entire D-Pax2 CNS gene (Fig. 1) rescues the D-
Pax2 function and expression in the CNS, which suggests that the complete CNS enhancer is 
confined to this genomic region.  By the use of lacZ reporter transgenes, we have mapped a 
conserved CNS enhancer element to the 6th intron of D-Pax2.  The 6th intron was able to 
drive lacZ expression specifically in the CNS, but it failed to reproduce the complete D-Pax2 
expression pattern.  Consistent with this observation, a rescue construct expressing D-Pax2 
under the control of the CNS promoter and 6th intron was unable to rescue CNS-null animals 
completely.  Therefore, the CNS enhancer in the 6th intron is incomplete and probably 
requires additional elements for wild-type expression and function.  We conclude that the D-
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Pax2 CNS enhancer consists of more than one DNA segment, probably located in other 
introns or downstream of the CNS transcription unit. 
 
 
 
Materials and methods 
 
Fly stocks 
The following fly stocks were used.  y w, ciD spapol, In(4)spa20 (Fu et al., 1998), svΔ122 (Shi, 
2001), svΔ122-P, sv12, sv14, D-Pax2 CNS-res, D-Pax2 CNS-lacZ, and l(4)2C2 (kindly provided 
by J. Kronhamn and A. Rasmuson-Lestander). 
 
S1 nuclease protection assay 
For the S1 nuclease protection assay, D-Pax2 oligonucleotides were obtained from 
Microsynth and labeled with 32P at their 5’end.  100 µg of total RNA isolated from 
Drosophila embryos (stages 14-17) or from a human embryonic kidney cell line, HEK 293, 
were used for hybridization, followed by S1 digestion performed as described (Weaver et al., 
1979).  Total RNA was isolated by TrIzol (Invitrogen) according to the manufacturer’s 
protocol.  The following probes were used (positions relative to the CNS transcription 
initiation site determined by 5’RACE are indicated, and the 10 nt of non-specific sequence 
added to the 3' end of each probe to monitor S1-nuclease activity are in lower case): 
 
Probe P1 (-31 to +69 ): 
5'CGTTTGTCTACTTCTTTGCATAAGTAAAGTGGACCGAGCACTCTCGTTGCTGTG
GCTTATTTTGTAGGTATGGTCTTCTTTAGTCAAGCCATTGACATTacgcaggcct3' 
 
Probe P2 (-85 to +20): 
5'CTGTGGCTTATTTTGTAGGTATGGTCTTCTTTAGTCAAGCCATTGACATTATTTT
TCTTTTATTTAAAAGCGTGTTTTCTCTTTCGTTTTGTGTACCGTAAAATtgatagcaat3' 
 
Probe P3 (-176 to -76): 
5'CCGTAAAATATTGCTAACCATTTTTTCCGGACTGTTTGCTGCCAGCCGCAGAGA
TTCTGCGCACGATTTCCTTATTCTTATCTACTTCTACAATTTTTGAGatagggacaa3' 
 
Probe P5 (-793 to -683): 
5'CCACAAAGAAGGTCTGTCATCGTGCGCAACGGCACCAATCACAGCACAACTTC
ATGCCTACTTCATTAACGTGTAGCCACTGAGCTTATCGACATCTCAAAgagtgagaac3' 
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RT-PCR analysis of D-Pax2 CNS transcripts 
Total RNA was extracted from Drosophila embryos (stages 14-17) using Nucleo Spin RNA 
II (MACHEREY NAGEL) kit according to the manufacturer’s instructions.  cDNA synthesis 
was carried out with the SuperScript™ II First-Strand cDNA synthesis kit (Invitrogen).  PCR 
reactions were then performed with a pfu polymerase to avoid undesired mutations.  PCR 
cycles are performed with 30 sec denaturation at 94°C, 30 sec annealing at 55°C, and 6 min 
extension at 72°C.  The last cycle is followed by a 10 min incubation at 72°C.  The DNA 
products were analyzed on 1.2% agarose gels.  The following primers were used in PCR 
reactions. 
CNS forward: 5'-GTTCCGGCATCGATTACAGGT-3' and 
CNS reverse: 5'-GTGTTGCTACTAAAGGTGAACG-3'. 
 
Generation of D-Pax2 null alleles by P-element imprecise excision 
All of over 100 imprecise excisions, except svΔ122 (type II in Fig. 10), of the P-element in 
l(4)2C2 which do not complement spapol, also deleted genes downstream of D-Pax2 (type IV 
in Fig. 10) and many if not most are terminal deletions of the 4th chromosome.  To isolate 
more type II, and hopefully slightly larger type III deletions, which inactivate the CNS 
transcription unit of D-Pax2 (type III in Fig. 10), the screen had to be modified such that no 
type IV deletions are obtained from the 250 individual F1 crosses.  This is the case in the 30 
independent F2 y w; 6.7-spa/+; ex(4)2C2/In(4)spa20 males with rough, spa-, eyes due to type 
I, II or III excision events since type IV deletions do not survive as they do not complement 
the lethal inversion breakpoint of In(4)spa20 in the downstream calsyntenin-1 gene (Fig. 10 
and Fig. 11, Fu et al., 1998).  The transgene 6.7-spa is needed since the inversion breakpoint 
upstream of the PNS promoter would be lethal over all mobilization events except clean (type 
0) excisions.  If the P-element remains in place or excises cleanly (type 0) or the excision 
creates a deletion towards upstream (type V) the flies have spa+ eyes.  Interestingly, the spa 
enhancer present in type I excision chromosomes does not activate the PNS promoter of the 
In(4)spa20 chromosome through transvection.  This is not that surprising because the spa 
enhancer in In(4)spa20 also cannot activate its promoter in cis nor in trans that of spapol in 
In(4)spa20/ciD spapol flies.  Apparently this inversion affects gene activation in D-Pax-2 from 
the PNS promoter in many aspects.  But for the survival of type III events it was needed that 
the inversion chromosome provided CNS function of D-Pax2 if it turns out to be vital.  It was 
impossible to establish these two facts before hand but CNS expression in homozygous 
embryos and later has a chance to be wild-type.  At least it is much closer to wild-type (data 
 73 
not shown) than PNS expression, which fades away in In(4)spa20 embryos (Fu, et al., 1998).  
Because type I deletions retain the spa enhancer which complements spapol through 
transvection (Chapter 3), 17 type I lines could be identified in F3.  Although at this stage of 
the scheme type II deletions are not distinguishable by adult phenotype from type III excision 
events we were hopeful that the rationale of the screen has worked since 5 type II or III 
deletions were obtained in F3 as spa- flies and the region where the right breakpoint could lie 
in is much smaller for type II, about 1.9 kb, than for type III deletions, about 15.5 kb.  
Because the y w; 6.7-spa/+; ex(4)2C2/ciD spapol are however not distinguishable by 
phenotype from their y w; 6.7-spa/+; In(4)spa20/ciD spapol siblings a stock with the genotype 
of the other siblings, with the genotype of the F2 father, y w; 6.7-spa/+; ex(4)2C2/In(4)spa20, 
was maintained while the new type II or III chromosomes were isolated from 6 single F3 
males from each line.  We knew that from this stock In(4)spa20 can be lost in the case of type 
II deletions, and possibly also type III deletions, if the CNS function is not vital.  Otherwise it 
is a balanced stock for type III deletions.  In the spa- ciD stocks established from single F3 
males without the 6.7-spa transgene the new type II or III chromosomes were identified and 
distinguished from In(4)spa20 on the basis of the absence of the PCR product across the 
downstream breakpoint of In(4)spa20 which is not expected to be present in the “simple” type 
II or III deletion alleles.  This worked for all 5 candidates and D-Pax2 expression analysis 
showed then that 4 type III deletions, among them sv12 and sv14, were obtained since they 
showed no D-Pax2 expression at all in homozygous embryos.  The fifth candidate, sv20, is of 
type II because it shows D-Pax2 expression in the CNS which was not surprising anymore 
because already a sv20 homozygous stock with the 6.7-spa transgene was established which 
had lost the ciD spapol chromosome.  The sv12 allele deletes 17’726 bp starting from the P-
element insertion site (Fig. 10 and 1).  But 363 bp of the P-element’s left end remained at the 
location of P-element insertion site.  The sv14 allele deletes 26’974 bp, the entire D-Pax2 
transcription unit (Fig. 10 and 1).  Here 30 bp of intronic sequence of the third downstream 
gene, CG-11155, are now at the location of the P-element.  It is not known if the deleted 
DNA has inserted in the 4th chromosome, or elsewhere, without giving rise to detectable D-
Pax2 protein, since no Southern blot analysis has been performed. 
 
Plasmid construction and generation of transgenic flies 
To rescue the CNS function of D-Pax2, the D-Pax2 CNS-res construct (Fig. 1) was prepared 
by cloning the genomic KpnI-NotI fragment and the adjacent KpnI fragment from the 
genomic clones PX11 and PX15 (Fu and Noll, 1997), respectively, sequentially into the 
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multiple cloning site of the P-element vector pW8.  To map the D-Pax2 CNS enhancer, the 
PlacW-like vector, PlacW8, was prepared by cloning the HindIII-EcoRI fragment of the 
PlacW plasmid (obtained from Werner Boll), containing part of the P-element promoter and 
the lacZ gene, between the HindIII site of the P-element promoter and the EcoRI site of the 
polylinker of the P-element vector pW8.  The 6th intron of D-Pax2 and the downstream 
intergenic region were amplified by PCR with corresponding restriction sites at their ends 
and cloned into the multiple cloning site of PlacW8.  The following oligonucleotides were 
used as primers in the PCR: 
intron 6-forward: 5'-CCGCTCGAGGCTTGGGAGATACGAGATCG-3', 
intron 6-reverse: 5'-CGCGGATCCGCTGCTGGTGATGATGTACG-3', 
downstream intergenic forward: 5'-CGCGGATCCGTCGCTCATGGTCGTGTAGG-3', 
downstream intergenic reverse: 5'-CCGCTCGAGGGAGGAAGTTTCTCCGTCCC-3'. 
 
To test the ability of intron 6 to activate transcription from the CNS promoter, we have 
generated D-Pax2-CNS-lacZ constructs.  The D-Pax2 -300 and -760 promoters and the CNS-
specific first exon were amplified by PCR with pfu polymerase and cloned in frame into the 
lacZ containing P-element vector pWZ.1 (Gutjahr et al., 1994).  Subsequently, the intron 6 
fragment of the PlacW8-intron 6 construct was cloned into this construct, upstream or 
downstream of the CNS promoter-lacZ gene.  The following primers were used for 
amplification of the CNS promoter regions: 
-300 bp CNS promoter: 
forward: 5'-CATTGGCTGCGGCCGCTAAGATGAAAACGCCAACCG-3', 
reverse: 5'-ATGGGTACCATTCCATCATGTTCTGGTTGTAGCG-3'. 
-760 bp CNS promoter: 
forward: 5'-CATTGGCTGCGGCCGCATGTCGATAAGCTCAGTGGC-3', 
reverse: 5'-ATGGGTACCATTCCATCATGTTCTGGTTGTAGCG-3'. 
 
For preparation of the CNS-specific D-Pax2 cDNA in PW8, the D-Pax2 cDNA was 
amplified by RT-PCR using total RNA isolated from Drosophila embryos (stages 14-17).  
Sequence analysis of the abundant D-Pax2 CNS-specific cDNA showed that exon 9 is 
spliced to exon 12.  The cDNA was cloned as XbaI-PstI fragment into the pSK+ plasmid and 
its 5' portion extended by a 1.5 kb NotI-XbaI fragment, taken from D-Pax2-CNS-lacZ and 
containing the -760 CNS promoter and a part of CNS exon 1.  The 3' portion downstream of 
exon 12 was replaced by a 2 kb genomic PstI-EcoRI fragment of PCG-2 (Fu et al., 1998).  
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This whole promoter-cDNA-genomic fragment was then cloned into the P-element vector 
pW8 and a 0.6 kb EcoRI fragment was added to its 3’ end in the correct orientation, like in 
PCG-2.  We have also prepared a CNS D-Pax2 construct where the region between exons 9 
and 12 contains genomic DNA by replacing the 919 bp SpeI fragment of the 3' portion by the 
corresponding 3.3 kb SpeI fragment from PCG-2.  This results in the inclusion of all introns 
downstream of exon 9.  Finally, intron 6 was cloned as 2.5 kb XhoI-NotI from the PlacW8-
intron 6 plasmid into both constructs upstream of the D-Pax2 CNS promoter in its normal 
orientation. 
 
Immunohistochemistry and microscopy 
Embryos were fixed and stained as described (Fu and Noll, 1997).  The following antibodies 
were used:  rabbit anti-D-Pax2 antiserum (Fu and Noll, 1997) and rabbit anti-LacZ 
polyclonal antibody (Cappel) at a 1:2,000 dilution, or chicken polyclonal anti-LacZ antibody 
(Abcam) at a 1:250 dilution.  Alexa 488-conjugated goat anti-rabbit and Alexa 594-
conjugated goat anti-chicken secondary antibodies were used at a 1:500 dilution (Invitrogen).  
Biotinylated secondary antibodies against rabbit IgG (Vector Laboratories, Inc.) were used at 
a 1:300 dilution.  For the color reaction, Vectastain ABC Kit (Vector Laboratories, Inc.) was 
used.  Anti-D-Pax2 staining was enhanced by the use of the TSATM kit (Invitrogen).  
Microscopy was carried out with a LEICA TCS SP confocal microscope.  Images were 
processed with Adobe Photoshop 7.0 and ImageJ.  
 
Scanning electron microscopy 
Scanning electron micrographs of adult fly eyes were taken on a JEOL JSM-6360 LV 
scanning electron microscope.  Female left eyes were pictured at a magnification of 220x. 
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Fig. 2.  Absence of D-Pax2 expression in sv12 and sv14 embryos and its rescue by a CNS 
rescue transgene. 
(A-D) Expression patterns of D-Pax2 protein are shown in ventral views of stage 15 sv12/ciD 
spapol (A), sv12 (B), sv14 (C), and D-Pax2 CNS-res2; sv14 (D) embryos. 
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Fig. 3.  The D-Pax2 null alleles do not complement spapol. 
(A-C) Scanning electron micrographs of y w (A), sv12/spapol (B), sv14/spapol (C) adult 
left eyes. 
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Fig.4.  The CNS enhancer is not located in the upstream region of D-Pax2. 
(A-C) Expression patterns of LacZ in l(4)2C2/ciD spapol (A), sv26.2 (B), and sv51.1 (C) 
embryos.  Ventral views of embryos with anterior to the left are shown. 
 82 
    
Fi
g.
 5
.  
V
ist
a 
pl
ot
 o
f D
-P
ax
2 
of
 se
ve
ra
l D
ro
so
ph
ila
 sp
ec
ie
s, 
ill
us
tr
at
in
g 
hi
gh
 c
on
se
rv
at
io
n 
of
 D
N
A
 se
qu
en
ce
s. 
Th
e 
re
la
tiv
e 
co
ns
er
va
tio
n,
 a
bo
ve
 5
0%
 id
en
tit
y 
in
 a
 1
00
 b
p 
w
in
do
w
, o
f t
he
 D
-P
ax
2 
D
N
A
 s
eq
ue
nc
e 
fr
om
 D
ro
so
ph
ila
 m
el
an
og
as
te
r 
to
 th
at
 o
f 
fiv
e 
ot
he
r D
ro
so
ph
ila
 sp
ec
ie
s (
in
di
ca
te
d 
in
 th
e 
rig
ht
 m
ar
gi
n)
 is
 sh
ow
n 
as
 V
is
ta
 p
lo
t b
el
ow
 th
e 
co
rr
es
po
nd
in
g 
m
ap
 o
f t
he
 D
-P
ax
2 
ge
ne
. 
 
 83 
 
 
 
Fig. 6.  Embryonic LacZ expression patterns of PlacW8 reporter genes. 
(A) Schematic representation of PlacW8 vector.  (B-G) Expression of lacZ under the control 
of D-Pax2 intron 6 (B-E) or downstream intergenic region (F,G).  Ventral views of stage 15 
embryos oriented with anterior to the left are shown. 
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Fig. 7.  Intron 6 of D-Pax2 contains CNS enhancer activity. 
(A) Schematic representation of D-Pax2-CNS-lacZ reporter construct with intron 6 upstream 
of the CNS promoter.  (B) LacZ expressions patterns of four different lines with transgene 
shown in (A) in ventral nerve chords dissected from stage 15 embryos, oriented with anterior 
to the left. 
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Fig. 8.  D-Pax2 CNS enhancer of intron 6 is incomplete. 
(A,B) Confocal images of cells in embryonic CNS expressing D-Pax2 (A) and LacZ (B).  
Most LacZ expressing cells (green) also express D-Pax2 (red), but not all cells that express 
D-Pax2 also express LacZ, as evident from the overlay of the two channels (C) and ImageJ 
co-localization (D). 
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Fig. 9.  S1 nuclease mapping of CNS-specific initiation site of D-Pax2 transcription. 
(A) Schematic representation of region including the D-Pax2 CNS promoter.  The horizontal 
arrow indicates the direction of transcription from the transcription start site determined by 
5’RACE.  Below, black bars denote the positions of the single-stranded antisense probes (P1-
P3 and P5) used for S1 nuclease mapping.  The open box on the left represents the 5’ end of 
the region deleted in the svΔ122-P allele.  (B) Analysis of protected probes after S1 nuclease 
digestion by denaturing PAGE.  Single-stranded probes P1-P3 and P5, 32P-labeled at their 5’ 
end, were hybridized with total RNA, isolated from the Drosophila embryos of indicated 
genotype or from human HEK cells, digested with S1 nuclease, analyzed by electrophoresis 
in a 10% polyacrylamide/8 M urea gel, and the protected labeled fragments analyzed by 
autoradiography.  The free labeled probes (diluted 1:100) are shown in lanes 13-16.  A 
marker is shown at the left, and the arrowhead points at the protected band of 70 nucleotides 
length.
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Fig. 11.  Crossing scheme for the generation of D-Pax2 null alleles. 
The phenotypes scored for in the offspring of the F1 and F2 crosses are in indicated in red. 
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Chapter 5 
 
Conclusions and Outlook 
 
D-Pax2, also known as shaven (sv) or sparkling (spa), encodes a paired domain containing 
transcription factor (Fu and Noll, 1997; Fu et al., 1998; Kavaler et al., 1999).  In Drosophila 
development, it plays important roles in developing eyes and the developing peripheral 
nervous system (PNS), including the adult mechanosensory bristles (Fu and Noll, 1997; Fu et 
al., 1998; Kavaler et al., 1999).  While its sv enhancer regulating transcription in the PNS is 
located upstream of the PNS promoter (Kavaler et al., 1999; Shi, 2001), the eye-specific spa 
enhancer is included in the 4th-intron (Fu and Noll, 1997).  In addition, D-Pax2 is expressed 
in the embryonic CNS (Fu and Noll, 1997), where it is transcribed from a different promoter, 
the CNS promoter (E. Frei, M. Daube, and M. Noll, unpublished).  In my thesis I have 
addressed two important problems concerning the transcriptional regulation of this genetic 
locus with its two promoters and several tissue-specific enhancers, the specificity between 
enhancers and promoters and the phenomenon of inter-allelic complementation or 
transvection. 
 
Enhancer-promoter specificity at the D-Pax2 locus 
The specificity between an enhancer and its cognate promoter has been a fundamental 
question in gene regulation (Li and Noll, 1994).  The mechanisms mediating the enhancer-
promoter specificity are not well studied.  In this report, we could demonstrate a clear case of 
enhancer-promoter specificity within a single gene, the D-Pax2 gene.  The sv enhancer and 
the spa enhancer specifically activate the PNS promoter but are unable to regulate the CNS 
promoter, whereas the CNS enhancer can only activate the CNS promoter.  Even though the 
spa enhancer is close to the CNS promoter and much closer than to its cognate PNS promoter 
(Fig. 1 of Chapter 2), it cannot activate the CNS promoter.  Similarly, the sv enhancer cannot 
activate the CNS promoter in the PNS, neither in the absence of the PNS promoter when this 
promoter was deleted, nor when brought by a deletion into close proximity of the CNS 
promoter.  These experiments have excluded the alternative models of promoter competition 
and insulator DNA elements mediating the enhancer-promoter specificity at this locus.  Thus, 
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the enhancer-promoter specificity at the D-Pax2 locus can only be explained by the 
compatibility between the enhancers and their cognate promoters, as shown previously for 
other genes (Li and Noll, 1994; Merli et al., 1996).  Experiments with the more promiscuous 
P-element promoter further suggested that the promoters rather than the enhancers control the 
specificity between enhancers and their promoters because both the sv enhancer and the CNS 
enhancer, which exclusively activate their cognate promoters, can activate the P-element 
promoter.  Therefore, characterizing the regulatory sequences of these promoters and the 
protein factors interacting with them is expected to shed light on the molecular mechanism 
regulating the compatibility between enhancers and promoters and thus transcriptional 
specificity. 
 
Transvection at the D-Pax2 locus 
Ed Lewis, discovered the genetic phenomenon of pairing-dependent inter-allelic 
complementation at the Ultrabithorax (Ubx) locus of Drosophila and called it transvection 
(Lewis, 1954).  Its molecular basis turned out to be the ability of an enhancer to activate 
transcription from its cognate promoter located on the paired homologous chromosome 
(Morris et al., 1998; Morris et al., 1999).  We found D-Pax2 to be a novel locus with the 
property of transvection.  The complementation of the spa enhancer deficiency, spapol, with 
the promoter deletion allele, sv11A, produced a nearly wild-type eye that contrasts the strong 
rough eye phenotype of spapol flies.  Since the spa enhancer can act only through the PNS 
promoter, this complementation of spapol with sv11A in the eye can be explained only by 
transvection, i.e., by the activation of D-Pax2 transcription through the intact spa enhancer of 
the sv11A allele acting on the intact PNS promoter of the spapol allele in the developing eye 
imaginal disc.  This conclusion was corroborated by direct identification of the D-Pax2 
transcripts produced in the eye disc by RT-PCR.  Only shortened transcripts originating from 
the spapol chromosome and no wild-type D-Pax2 transcripts were found.  Interestingly, the 
spa enhancer was able to activate transcription from the promoter in cis and as well as in 
trans.  In contrast to the spa enhancer, the sv enhancer does not support transvection.  The sv 
enhancer deletion allele, svX14P, did not complement the promoter deletion allele, sv11A.  
Analysis of D-Pax2 transcripts by qRT-PCR showed that the sv enhancer is able to activate 
transcription minimally in trans, at a level that is not sufficient for complementation.  These 
results strongly suggest that transvection is a property of the enhancer, but not of the 
promoter, as of two different enhancers activating the same promoter in cis only one can 
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activate it in trans at a level sufficient to complement the lacking function.  In addition, this 
property has a quantitative aspect, as evident from a slight suppression of the strong lack-of-
function phenotype by the sv enhancer acting in trans.  Thus, transvection at the D-Pax2 
locus depends on the properties of the individual enhancers.  As Erich Frei in our lab aptly 
coined it: “Not every “cis-enhancer” is also a “trans-enhancer”. 
 
These contrasting properties of D-Pax2 enhancers to support transvection provide an ideal 
system for future studies investigating the molecular mechanisms of transvection.  In 
addition, it will be interesting to test the D-Pax2 enhancers for transvection at ectopic loci of 
this gene, (i) to test whether transvection of D-Pax2 depends on the pairing of the alleles, the 
original test of Ed Lewis, and (ii) to test whether the results obtained at the D-Pax2 locus can 
be reproduced in a different chromosomal environment.  It is possible to test this by using the 
PhiC31 integrase system (Bischof et al., 2007).  Preliminary experiments confirm our 
conclusions. 
 
D-Pax2 function in the CNS 
We have generated D-Pax2 null alleles, sv12 and sv14, that contain deletions uncovering the 
PNS as well as the CNS transcription units (Chapter 4, Fig.1).  Homozygous sv12 and sv14 
embryos show complete loss of D-Pax2 expression in the PNS and CNS and die as first instar 
larvae.  These animals cannot be rescued to adults by merely providing the PNS function of 
D-Pax2.  Therefore, D-Pax2 function in the CNS is also vital for development to adulthood.  
To understand the molecular role of D-Pax2 in the Drosophila CNS development, however, a 
detailed analysis of its expression at the cellular level during development is indispensable.  
Genetic experiments, confirmed by 5´ RACE, indicated that transcription in the CNS starts 
from a second promoter of D-Pax2, the CNS promoter.  This transcription initiation site was 
further corroborated by S1 nuclease mapping.  Since the genomic transgene, D-Pax2 CNS-
res, containing the complete D-Pax2 CNS transcription unit, was able to rescue expression 
and function of D-Pax2 in the CNS, the CNS enhancer could be localized to this region of the 
D-Pax2 gene.  Finally, we have found a conserved element in intron 6 that is able to drive 
lacZ expression in the CNS similar to D-Pax2.  Intron 6 comprises a crucial, but not 
complete, CNS enhancer since CNS-specific D-Pax2 cDNA under the control of intron 6 and 
the CNS promoter is able to rescue the lethality of CNS loss-of-function animals to about 
50% viability.  We speculate that additional CNS enhancer elements are required for 
complete rescue.  Thus, it appears that the CNS enhancer is a complex enhancer consisting of 
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more than one region separated by exons, as we have encountered it for enhancers of the 
other Pax2-like gene of Drosophila, Pox neuro (Boll and Noll, 2002). 
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